Departament Medicina
Memòria 2006
Docència, recerca i economia
1
Índex
Docència
Llicenciatura ...............................................................................................5
Doctorat.......................................................................................................7
Recerca
Dermatologia...............................................................................................10
Malalties de la sang.....................................................................................12
Malalties de l'aparell càrdio-circulatori ......................................................14
Malalties de l'aparell digestiu ....................................................................16
Malalties de l'aparell respiratori..................................................................23
Malalties del sistema endocrí i de la nutrició..............................................32
Malalties del sistema excretor renal i genital masculí ................................35
Malalties del sistema nerviós ......................................................................36
Malalties infeccioses ..................................................................................40
Malalties reumatològiques i del sistema immune.......................................46
Medicina d'atenció primària........................................................................49
Oncologia clínica ........................................................................................53
Semiologia general i propedèutica..............................................................54
Hospitals col•laboradors .............................................................................56
Economia
Funcionament ordinari ................................................................................61
2
Docència
3
4
Llicenciatura
(Alumnes del curs 2006-2007)
Assignatures troncals
Crèdits Teoria
Cr. Pràctiques Total Núm. Alumnes
3er. Curs
Semiologia general i propedèutica.......................................
6
16
22
181
4rt. Curs
Malalties de l'aparell càrdio-circulatori...............................
2,5
10,5
13
149
Malalties de l'aparell respiratori..........................................
Malalties de la sang.............................................................
Oncologia clínica ................................................................
Malalties de l'aparell digestiu .............................................
Malalties del sistema nerviós...............................................
Malalties del sistema endocrí i de la nutrició......................
2,5
2,5
2,5
2,5
2,5
4
10,5
2
2
10,5
10,5
3
13
4,5
4,5
13
13
7
157
155
156
152
151
158
5è. Curs
Dermatologia......................................................................
Medicina d'atenció primària...............................................
Malalties del sistema excretor renal i genital masculí........
Malalties infeccioses .........................................................
Malalties reumatològiques i del sistema immune .............
3
1
2,5
3,5
2
4
7
10,5
5
3
7
8
13
8,5
5
152
146
163
149
140
4,5
4,5
4,5
6
4,5
4,5
60
49
34
48
35
35
Assignatures optatives
Atenció multidisciplinària en el pacient vell ....................
Elements diagnòstics en medicina interna .......................
Hematologia biològica. Diagnòstic de laboratori ............
Indroducció al diagnòstic i tractament del malalt crític ..
Redacció mèdica .............................................................
Síndrome d'immunodeficiència adquirida ......................
4,5
4,5
4,5
6
4,5
4,5
Assignatures optatives com a treball pràctic
Assistència clínica en zones urbanes socialment deprimides
Total................................................................................
5
15
65,5
15
6
109,5 175
2.276
Hospitals i Centres de Salut i Atenció Primària associats al Departament de Medicina
Hospital Clínic i Provincial de Barcelona
Hospital Dos de Maig
Hospital Esperit Sant
Hospital General de Granollers
Hospital General de l'Hospitalet
Hospital Mútua de Terrassa
CAPSE Rosselló
EAP Casanovas CAPSE
EAP Casc Antic
EAP Dr Carles Ribas
EAP El Clot
EAP Gòtic
EAP La Marina
EAP La Mina
EAP La Pau
EAP Les Corts
EAP Manso 2A Sant Antoni
EAP Manso 2B Via Roma Manso
EAP Poble Nou
EAP Raval Nord Centre Dr. Lluis Sayé
EAP Raval Sud
6
Doctorat
Programa Biopatologia en Medicina:
2n any
36 alumnes
Tesis aprovades:
17 Per publicacions
5 Format clàssic
Total: 22 tesis aprovades
Projectes de tesis d'alumnes amb suficiència investigadora inscrits pendents de presentar la tesi:
Inscrits abans de 1998
Alumnes de doctorat pla vell........
Alumnes de doctorat pla 98..........
Total......................
63
7
Inscrits desprès de 1998
Total
25
28
88
28
116
8
Recerca
9
Dermatologia
Dermatologia - Publicacions 2006
Títol
Original
Aberrant nuclear BCL10 expression
and lack of t(11;18)(q21;q21) in
primary cutaneous marginal zone Bcell lymphoma.
Dermoscopy in epidermodysplasia
verruciformis.
Autors
Cita
Gallardo F; Bellosillo B; Espinet B; Pujol RM;
Estrach T; Servitje O; Romagosa V; Barranco C;
Boluda S; Garcia M; Sole F; Ariza A; Serrano S
Human pathology; 2006 Jul; 37(7); p.
867-73
Segura S; Carrera C; Ferrando J; Mascaro JM Jr;
Palou J; Malvehy J; Puig S
Dermatologic surgery : official
publication for American Society for
Dermatologic Surgery [et al]; 2006
Jan; 32(1); p. 103-6
Diffuse and segmental variants of Badeloe S; van Geel M; van Steensel MA; Bastida J; Experimental dermatology; 2006 Sep;
cutaneous leiomyomatosis: novel Ferrando J; Steijlen PM; Frank J; Poblete-Gutierrez 15(9); p. 735-41
mutations in the fumarate hydratase P
gene and review of the literature
EORTC consensus
Trautinger F; Knobler R; Willemze R; Peris K;
European journal of cancer (Oxford,
recommendations for the treatment Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli England : 1990); 2006 May; 42(8); p.
of mycosis fungoides/Sezary
N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker 1014-30
syndrome
S
Eosinophilic ulcer of the oral
Segura S; Romero D; Mascaro JM Jr; Colomo L;
The British journal of dermatology;
mucosa: another histological
Ferrando J; Estrach T
2006 Aug; 155(2); p. 460-3
simulator of CD30+
lymphoproliferative disorders.
Genetic and biochemical
To-Figueras J; Badenas C; Carrera C; Munoz C; Mila Journal of inherited metabolic disease;
characterization of 16 acute
M; Lecha M; Herrero C
2006 Aug; 29(4); p. 580
intermittent porphyria cases with a
high prevalence of the R173W
mutation
Genetic and biochemical
To-Figueras J; Badenas C; Carrera C; Munoz C; Mila Journal of inherited metabolic disease;
characterization of 16 acute
M; Lecha M; Herrero C
2006 Aug; 29(4); p. 580
intermittent porphyria cases with a
high prevalence of the R173W
mutation.
Genetic studies in variegate
Lecha M; Badenas C; Puig S; Orfila J; Mila M; ToJournal of the European Academy of
porphyria in Spain. Identification of Figueras J; Munoz C; Mercader P; Herrero C
Dermatology and Venereology :
gene mutations and family study for
JEADV; 2006 Sep; 20(8); p. 974-9
carrier detection
Genetic studies in variegate
Lecha M; Badenas C; Puig S; Orfila J; Mila M; Toournal of the European Academy of
porphyria in Spain. Identification of Figueras J; Munoz C; Mercader P; Herrero C
Dermatology and Venereology :
gene mutations and family study for
JEADV; 2006 Sep; 20(8); p. 974-9
carrier detection
Immunoadsorption against two
Herrero-Gonzalez JE; Brauns O; Egner R; Ronspeck European journal of immunology; 2006
distinct epitopes on human type
W; Mascaro JM Jr; Jonkman MF; Zillikens D; Sitaru Apr; 36(4); p. 1039-48
XVII collagen abolishes dermalC
epidermal separation induced in
vitro by autoantibodies from
pemphigoid gestationis patients
10
National registry of Home Enteral
Nutrition in 2003
Results of radiotherapy in primary
cutaneous lymphoma
The prevalence of HFE C282Y
gene mutation is increased in
Spanish patients with porphyria
cutanea tarda without hepatitis C
virus infection
Treatment of patients with atopic
dermatitis using wet-wrap dressings
with diluted steroids and/or
emollients. An expert panel's
opinion and review of the literature.
Cas Clínic
An embossed tattoo
Planas M; Lecha M; Garcia Luna PP; Pares RM;
Chamorro J; Marti E; Bonada A; Irles JA; Boris MA;
Cardona D; Zamarron I; Calanas AJ; Rodriguez A;
Camarero E; Perez de la Cruz A; Mancha A; De Luis
Roman D; Cos A; Luengo LM; Jimenez M; Bayo P;
Goenaga MA
Conill C; Navalpotro B; Lopez I; Estrach T
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C;
Ercilla MG
Oranje AP; Devillers AC; Kunz B; Jones SL;
DeRaeve L; Van Gysel D; de Waard-van der Spek
FB; Grimalt R; Torrelo A; Stevens J; Harper J
Nutricion hospitalaria : organo oficial
de la Sociedad Espanola de Nutricion
Parenteral y Enteral; 2006 Jan-Feb;
21(1); p. 71-4
Clinical & translational oncology :
official publication of the Federation of
Spanish Oncology Societies and of the
National Cancer Institute of Mexico;
2006 Jun; 8(6); p. 430-4
Journal of the European Academy of
Dermatology and Venereology :
JEADV; 2006 Nov; 20(10); p. 1201-6
Journal of the European Academy of
Dermatology and Venereology :
JEADV; 2006 Nov; 20(10); p. 1277-86
Munoz C; Guilabert A; Mascaro JM Jr; Lopez-Lerma Clinical and experimental
I; Vilaplana J
dermatology; 2006 Mar; 31(2); p. 30910
Atypical pemphigus: discordance
Herrero-Gonzalez JE; Mascaro JM Jr; Iranzo P;
Journal of cutaneous pathology; 2006
between clinicopathological findings Herrero C
Jul; 33(7); p. 502-7
and the antigenic profile in four
cases
Carta
Autoantibodies from patients with Herrero-Gonzalez JE; Mascaro JM Jr; Herrero C;
Archives of dermatology; 2006 Nov;
BSLE inducing recruitment of
Dilling A; Zillikens D; Sitaru C
142(11); p. 1513
leukocytes to the dermoepidermal
junction and subepidermal splits in
cryosections of human skin.
Compound blue naevus: a potential Carrera C; Ferrer B; Mascaro JM Jr; Palou J
The British journal of dermatology;
simulator of melanoma
2006 Jul; 155(1); p. 207-8
Erythema multiforme presenting as Carrera C; Alsina M; de Pablo IM; Iranzo P; Herrero Journal of the European Academy of
cholestatic acute hepatitis caused C
Dermatology and Venereology :
by Epstein-Barr virus
JEADV; 2006 Nov; 20(10); p. 1350-2
Haemochromatosis gene mutations Toll A; Celis R; Ozalla MD; Ercilla MG; Herrero C
Acta dermato-venereologica; 2006;
and response to chloroquine in
86(3); p. 279-80
sporadic porphyria cutanea tarda.
Not all images serve more than a Moreno Romero JA; Guilabert Vidal A; MascaroMedicina clinica; 2006 Oct 14;
thousand words
Galy JM; Ferrando J
127(14); p. 558
Where has all that hair gone?
Cutrone M; Grimalt R
Clinical and experimental
dermatology; 2006 Jan; 31(1); p. 1367
11
Malalties de la Sang
Malalties de la Sang - Publicacions 2006
Títol
Autors
Original
Anti-D alloimmunization after DCid J, Lozano M, Fernandez F, Carreras E, Pereira
mismatchet allogeneic
A, Mazzara R, Ordinas A
hematopoietic stem cell
transplatation in patients with
hematologic diseases
Antithrombotic action of annexin V Galan AM; van Heerde WL; Escolar G; Ordinas A;
proved as efficient as direct
Sixma J; de Groot PG;
inhibition of tissue factor or thrombin
Argatroban: a direct thrombin
Escolar G; Bozzo J; Maragall S
inhibitor with reliable and
predictable anticoagulant actions
Assessment of platelet function in Segura D; Monreal L; Perez-Pujol S; Pino M;
horses: ultrastructure, flow
Ordinas A; Brugues R; White JG; Escolar G
cytometry, and perfusion techniques
Coding sequence and intron-exon
junctions of the c-myb gene are
intact in the chronic phase and blast
crisis stages of chronic myeloid
leukemia patients
Darbepoetin-alpha for the anaemia
of myelofibrosis with myeloid
metaplasia
Effects of etamsylate on equine
platelets: In vitro and in vivo studies
Effects of polyethylene glycol and
hydroxyethyl starch in University of
Wisconsin preservation solution on
human red blood cell aggregation
and viscosity
Effects on primary haemostasis of
an anti-inflammatory agent with 5lipoxygenase and cyclooxygenase
inhibitory activity
Five-year follow-up of patients
receiving imatinib for chronic
myeloid leukemia
Bussolari R; Candini O; Colomer D; Corradini F;
Guerzoni C; Mariani SA; Cattelani S; Silvestri C;
Pecorari L; Iacobucci I; Soverini S; Fasano T;
Martinelli G; Cervantes F; Calabretta B
Cita
Transfusion 2006;46:169-69
European journal of clinical
investigation; 2006 Sep; 36(9); p. 6339
Drugs of today (Barcelona, Spain :
1998); 2006 Apr; 42(4); p. 223-36
Journal of veterinary internal medicine
/ American College of Veterinary
Internal Medicine; 2006 May-Jun;
20(3); p. 581-8
Leukemia research; 2007 Feb; 31(2);
p. 163-7
Cervantes F; Alvarez-Larran A; Hernandez-Boluda
JC; Sureda A; Granell M; Vallansot R; Besses C;
Montserrat E
Segura D; Monreal L; Perez-Pujol S; Alonso A; DiazRicart M; Brugues R; Ordinas A; Escolar G
Mosbah IB; Franco-Gou R; Abdennebi HB;
Hernandez R; Escolar G; Saidane D; RoselloCatafau J; Peralta C
British journal of haematology; 2006
Jul; 134(2); p. 184-6
Hernandez MR; Tonda R; Pedreno J; Salas E;
Arderiu G; Pino M; Serradell M; Escolar G
Journal of cardiovascular medicine
(Hagerstown, Md); 2006 Dec; 7(12); p.
859-65
Veterinary journal (London, England :
1997); 2006 Aug 9;
Transplantation proceedings; 2006
Jun; 38(5); p. 1229-35
Druker BJ; Guilhot F; O'Brien SG; Gathmann I;
The New England journal of medicine;
Kantarjian H; Gattermann N; Deininger MW; Silver 2006 Dec 7; 355(23); p. 2408
RT; Goldman JM; Stone RM; Cervantes F;
Hochhaus A; Powell BL; Gabrilove JL; Rousselot P;
Reiffers J; Cornelissen JJ; Hughes T; Agis H;
Fischer T; Verhoef G; Sh
Cervantes F; Alvarez-Larran A; Arellano-Rodrigo E; Leukemia; 2006 Jan; 20(1); p. 55-60
Granell M; Domingo A; Montserrat E
Frequency and risk factors for
thrombosis in idiopathic
myelofibrosis: analysis in a series of
155 patients from a single institution
Guidelines of the Spanish Society of Marin R; Goicoechea MA; Gorostidi M; Cases A;
Nephrology: the kidney and
Diez J; Escolar G; Fernandez-Vega F; Palomar R;
cardiovascular disease. Short
Rodrigo E; Martinez I; Segura J
version
12
Nefrologia : publicacion oficial de la
Sociedad Espanola Nefrologia; 2006;
26(1); p. 31-44
Increased platelet and leukocyte
Arellano-Rodrigo E; Alvarez-Larran A; Reverter JC;
activation as contributing
Villamor N; Colomer D; Cervantes F
mechanisms for thrombosis in
essential thrombocythemia and
correlation with the JAK2 mutational
status
Rivaroxaban
Escolar G, Villalta J, Casals F, Bozzo J, Serradell N,
Bolós J
Serotonergic mechanisms: a
Escolar G; Diaz-Ricart M; Gomez-Gil E; Serra M;
potential link between affective
Gasto C; Bozzo J; Galan AM
disorders and cardiovascular risk.
Serotoninergic mechanisms: a
G Escolar, M Díaz-Ricart, E Gómez-Gil, M Serra, C
potential link between affective
Gastó, J Bozzo, AM Galán
disorders and cardiovascular risk
Studies of complex Ph
Costa D; Carrio A; Madrigal I; Arias A; Valera A;
translocations in cases with chronic Colomer D; Aguilar JL; Teixido M; Camos M;
myelogenous leukemia and one
Cervantes F; Campo E
with acute lymphoblastic leukemia
Revisió
Evolving concepts in the
Baccarani M; Saglio G; Goldman J; Hochhaus A;
management of chronic myeloid
Simonsson B; Appelbaum F; Apperley J; Cervantes
leukemia: recommendations from F; Cortes J; Deininger M; Gratwohl A; Guilhot F;
an expert panel on behalf of the
Horowitz M; Hughes T; Kantarjian H; Larson R;
European LeukemiaNet
Niederwieser D; Silver R; Hehlmann R
International Working Group (IWG) Tefferi A; Barosi G; Mesa RA; Cervantes F; Deeg
consensus criteria for treatment
HJ; Reilly JT; Verstovsek S; Dupriez B; Silver RT;
response in myelofibrosis with
Odenike O; Cortes J; Wadleigh M; Solberg LA Jr;
myeloid metaplasia, for the IWG for Camoriano JK; Gisslinger H; Noel P; Thiele J;
Myelofibrosis Research and
Vardiman JW; Hoffman R; Cross NC; Gilliland DG;
Treatment (IWG-MRT)
Kantarjian H
Myelofibrosis with myeloid
Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
metaplasia: disease overview and
non-transplant treatment options
Haematologica; 2006 Feb; 91(2); p.
169-75
Drug Future 2006; 31(6):484-493
Timely topics in medicine
Cardiovascular diseases; 2006 Feb 1;
10; p. E3
Timely Top Med Cardiovasc Dis :
10:E3; 2006
Cancer genetics and cytogenetics;
2006 Apr 1; 166(1); p. 89-93
Blood; 2006 Sep 15; 108(6); p. 180920
Blood; 2006 Sep 1; 108(5); p. 1497503
Best practice & research Clinical
haematology; 2006; 19(3); p. 495-517
Malalties de la sang - Projectes finançats 2006
Investigador Principal
Referència Ajut
Entitat
Nom Projecte
Import
Durada
Cervantes F
U-2006FS060038-O
FIS
Estudio de la relación entre la presencia de polimorfismos
genéticos en los genes MDR1, hOCT1 y AGP1 y la respuesta
la tratamiento con imatinib en los pacientes con leucemia
mieloide crónica
62.900
2006-2008
Escolar G
PB-B1-10007
Ag. de Gestió
Cooperación del colágeno, factor tisular depositado y
d'Ajuts Universitaris desencriptado en la formación y propagación del trombo bajo
i de Recerca
condiciones de flujo
63.800
2006-2008
Escolar G
PTR1995-0890- Ministerio Ciencia y Desarrollo y evaluación toxicológica de prototipos de sustitivos 81.000
OP
Tecnología
sintéticos para los concentrados de plaquetas
2003-2006
Escolar G
SAF2003-05780 Ministerio de
Ciencia y
Tecnología
133.100
2003-2006
Escolar G
SAF2006-08003 Ministerio
Factor tisular circulante y asociado a las plaquetas: papel en la 137.000
Educación y Ciencia formación de trombos oclusivos sobre lesiones arteriales,
implicaciones fisiológicas, clínicas y terapéuticas
2006-2009
Ordinas A
2005RG009532 Ag. de Gestió
Grup de fisiopatologia, d'hemostàsia i trombosi
d'Ajuts Universitaris
i de Recerca
2005.2008
Cooperación del colágeno, factor tisular depositado y
desencriptado en la formación y propagación del trombo bajo
condiciones de flujo
13
31.600
Malalties de l'Aparell Càrdio-circulatori
Malalties Aparell Càrdio-circulatori - Publicacions 2006
Títol
Autors
Original
A Practical Approach With Outcome Sanchis J; Bodi V; Nunez J; Bosch MJ; Bertomeufor the Prognostic Assessment of Gonzalez V; Consuegra L; Santas E; Gomez C;
Non-ST-Segment Elevation Chest Bosch X; Chorro FJ; Llacer A
Pain and Normal Troponin
Anodal capture in cardiac
Tamborero D; Mont L; Alanis R; Berruezo A;
resynchronization therapy
Tolosana JM; Sitges M; Vidal B; Brugada J
implications for device programming
Clinical and echocardiographic
Delgado V; Sitges M; Andrea R; Rivera S; Masotti M;
follow-up of patients with
Francino A; Azqueta M; Pare C; Betriu A
hypertrophic obstructive
cardiomyopathy treated by
percutaneous septal ablation
Complications of Native
Anguera I; Del Rio A; Moreno A; Pare C; Mestres
andProsthetic Valve Infective
CA; Miro JM
Endocarditis: Update in 2006
Compound heterozygous mutations Cordeiro JM; Barajas-Martinez H; Hong K;
P336L and I1660V in the human
Burashnikov E; Pfeiffer R; Orsino AM; Wu YS; Hu D;
cardiac sodium channel associated Brugada J; Brugada P; Antzelevitch C; Dumaine R;
with the Brugada syndrome
Brugada R
Electrocardiogram interpretation
Brugada R; Brugada P; Brugada J
and class I blocker challenge in
Brugada syndrome
European Heart Rhythm
Auricchio A; Gropp M; Ludgate S; Vardas P;
Association Guidance Document on Brugada J; Priori SG
cardiac rhythm management
product performance
Familial pseudo-Wolff-ParkinsonWhite syndrome
Hemodialysis prospective
multicentric quality study
Hemodialysis prospective
multicentric quality study
Hemolysis in mechanical bileaflet
prostheses: experience with the
Bicarbon valve
Ischemic and bleeding outcomes in
women treated with bivalirudin
during percutaneous coronary
intervention: a subgroup analysis of
the Randomized Evaluation in PCI
Linking Angiomax to Reduced
Clinical Events (REPLACE)-2 trial
Sternick EB; Oliva A; Magalhaes LP; Gerken LM;
Hong K; Santana O; Brugada P; Brugada J;
Brugada R
Parra E; Ramos R; Betriu A; Paniagua J; Belart M;
Martin F; Martinez T
Parra E; Ramos R; Betriu A; Paniagua J; Belart M;
Martin F; Martinez T
Josa M; Castella M; Pare C; Bedini JL; Cartana R;
Mestres CA; Pomar JL; Mulet J
Cita
The American journal of cardiology;
2007 Mar 15; 99(6); p. 797-801
Pacing and clinical electrophysiology :
PACE; 2006 Sep; 29(9); p. 940-5
Revista espanola de cardiologia; 2006
Nov; 59(11); p. 1123-30
Current infectious disease reports;
2006 Jun; 8(4); p. 280-8
Circulation; 2006 Nov 7; 114(19); p.
2026-33
Journal of electrocardiology; 2006 Oct;
39(4 Suppl); p. S115-8
Europace : European pacing,
arrhythmias, and cardiac
electrophysiology : journal of the
working groups on cardiac pacing,
arrhythmias, and cardiac cellular
electrophysiology of the European
Society of Cardiology; 2006 May; 8(5);
p. 313-22
Journal of cardiovascular
electrophysiology; 2006 Jul; 17(7); p.
724-32
Nefrologia : publicacion oficial de la
Sociedad Espanola Nefrologia; 2006;
26(6); p. 688-94
Nefrologia; 2006; 26(6); p. 688-94
The Annals of thoracic surgery; 2006
Apr; 81(4); p. 1291-6
Chacko M; Lincoff AM; Wolski KE; Cohen DJ; Bittl American heart journal; 2006 May;
JA; Lansky AJ; Tsuchiya Y; Betriu A; Yen MH; Chew 151(5); p. 1032.e1-7
DP; Cho L; Topol EJ
14
Optimizing use of revascularization
and clinical outcomes in STelevation myocardial infarction:
insights from the GUSTO-V trial
Performance assessment of an
emergency department chest pain
unit
Periannular complications in
infective endocarditis involving
native aortic valves
Periannular complications in
infective endocarditis involving
prosthetic aortic valves
Kaul P; Chang WC; Lincoff AM; Aylward P; Betriu A; European heart journal; 2006 May;
Bode C; Califf RM; Ohman EM; Guetta V; Steg PG; 27(10); p. 1198-206
Van de Werf F; Armstrong PW
Bragulat E; Lopez B; Miro O; Coll-Vinent B; Jimenez
S; Aparicio MJ; Heras M; Bosch X; Valls V; Sanchez
M
Anguera I; Miro JM; Evangelista A; Cabell CH; San
Roman JA; Vilacosta I; Almirante B; Ripoll T;
Farinas MC; Anguita M; Navas E; GonzalezJuanatey C; Garcia-Bolao I; Munoz P; de Alarcon A;
Sarria C; Rufi G; Miralles F; Pare C; Fowler VG Jr;
Mestres CA; de
Anguera I; Miro JM; San Roman JA; de Alarcon A;
Anguita M; Almirante B; Evangelista A; Cabell CH;
Vilacosta I; Ripoll T; Munoz P; Navas E; GonzalezJuanatey C; Sarria C; Garcia-Bolao I; Farinas MC;
Rufi G; Miralles F; Pare C; Fowler VG Jr; Mestres
CA; de
Sanchis J; Bodi V; Nunez J; Bertomeu V;
Consuegra L; Bosch MJ; Gomez C; Bosch X;
Chorro FJ; Llacer A
Prognostic usefulness of white
blood cell count on admission and
one-year outcome in patients with
non-ST-segment elevation acute
chest pain
Recurrent syncope: an unusual
Benito B; Brugada J
presentation of Brugada syndrome
Relation of response to cardiac
resynchronization therapy to left
ventricular reverse remodeling
Specialized care program for endstage heart failure patients. Initial
experience in a heart failure unit
Sport practice and the risk of lone
atrial fibrillation: a case-control
study
Transient endothelial dysfunction is
present shortly after cardioversion
in patients with lone atrial fibrillation
Cas Clínic
Epicardial ablation of syncopal
ventricular tachycardia. Utility of the
electrocardiogram
Vidal B; Sitges M; Marigliano A; Diaz-Infante E;
Azqueta M; Tamborero D; Macias A; Roig E;
Brugada J; Pare C; Mont L
Roig E; Perez-Villa F; Cuppoletti A; Castillo M;
Hernandez N; Morales M; Betriu A
Images in cardiology. Left
ventricular pseudoaneurysm
complicating acute myocardial
infarction: improved diagnosis by
real time three dimensional
echocardiography
Freixa X; Sitges M; Pare C
Elosua R; Arquer A; Mont L; Sambola A; Molina L;
Garcia-Moran E; Brugada J; Marrugat J
Revista espanola de cardiologia; 2007
Mar; 60(3); p. 276-84
The American journal of cardiology;
2006 Nov 1; 98(9); p. 1254-60
The American journal of cardiology;
2006 Nov 1; 98(9); p. 1261-8
The American journal of cardiology;
2006 Oct 1; 98(7); p. 885-9
Nature clinical practice Cardiovascular
medicine; 2006 Oct; 3(10); p. 573-7;
quiz following 577
The American journal of cardiology;
2006 Mar 15; 97(6); p. 876-81
Revista espanola de cardiologia; 2006
Feb; 59(2); p. 109-16
International journal of cardiology;
2006 Apr 14; 108(3); p. 332-7
Coll-Vinent B; Monteagudo J; Miro O; Luis Marin J; Thrombosis research; 2006; 117(3); p.
Nava S; Scalise A; Sanchez M; Bragulat E; Sitges M; 235-40
Brugada J; Mont L
Berruezo A; Cano L; Mont L; Brugada J
15
Europace : European pacing,
arrhythmias, and cardiac
electrophysiology : journal of the
working groups on cardiac pacing,
arrhythmias, and cardiac cellular
electrophysiology of the European
Society of Cardiology; 2006 May; 8(5);
p. 338-40
Heart (British Cardiac Society); 2006
Feb; 92(2); p. 154
Malalties de l'Aparell Digestiu
Malalties de l'Aparell Digestiu - Publicacions 2006
Títol
Autors
Originals
A molecular signature to
Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI;
discriminate dysplastic nodules from Schwartz M; Thung SN; Khitrov G; Zhang W;
early hepatocellular carcinoma in
Villanueva A; Battiston C; Mazzaferro V; Bruix J;
HCV cirrhosis
Waxman S; Friedman SL
Acute gastroenteritis is followed by Garcia Rodriguez LA; Ruigomez A; Panes J
an increased risk of inflammatory
bowel disease
Adrenal insufficiency in patients with Fernandez J; Escorsell A; Zabalza M; Felipe V;
cirrhosis and septic shock: Effect of Navasa M; Mas A; Lacy AM; Gines P; Arroyo V
treatment with hydrocortisone on
survival.
Anti-inflammatory effects of lowArenas M; Gil F; Gironella M; Hernandez V; Jorcano
dose radiotherapy in an
S; Biete A; Pique JM; Panes J
experimental model of systemic
inflammation in mice
Anti-VCAM-1 antibodies did not
Justicia C; Martin A; Rojas S; Gironella M; Cervera
protect against ischemic damage
A; Panes J; Chamorro A; Planas AM
either in rats or in mice
Aquaporin-1 and aquaporin-2
Esteva-Font C; Baccaro ME; Fernandez-Llama P;
urinary excretion in cirrhosis:
Sans L; Guevara M; Ars E; Jimenez W; Arroyo V;
Relationship with ascites and
Ballarin JA; Gines P
hepatorenal syndrome
Ascorbic acid improves the
Hernandez-Guerra M; Garcia-Pagan JC; Turnes J;
intrahepatic endothelial dysfunction Bellot P; Deulofeu R; Abraldes JG; Bosch J
of patients with cirrhosis and portal
hypertension
Caroli's disease
Bruguera M; Ros E
Cation-pi Interactions and oxidative
effects on Cu+ and Cu2+ binding to
Phe, Tyr, Trp, and His amino acids
in the gas phase. Insights from firstprinciples calculations
Characterization and differentiation
of autoimmune versus viral liver
involvement in patients with
Sjogren's syndrome
Clinical practice guideline for
irritable bowel syndrome
Rimola A; Rodriguez-Santiago L; Sodupe M
Ramos-Casals M; Sanchez-Tapias JM; Pares A;
Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez
D; Arias I; Bove A; Plaza J; Rodes J; Font J
Tort S; Balboa A; Marzo M; Carrillo R; Minguez M;
Valdeperez J; Alonso-Coello P; Mascort JJ;
Ferrandiz J; Bonfill X; Pique JM; Mearin F
Consensus document on the use of Cabriada JL; Domenech E; Gomollon F; Gonzalezgranulocytapheresis in patients with Carro P; Gonzalez-Lara V; Hinojosa J; Jimenezinflammatory bowel disease
Lopez CE; Nos P; Obrador A; Panes J; Saro C;
Varea V; Lafuente R; Guilera M
Cyclooxygenase 2 expression in
Castells A; Paya A; Alenda C; Rodriguez-Moranta F;
colorectal cancer with DNA
Agrelo R; Andreu M; Pinol V; Castellvi-Bel S; Jover
mismatch repair deficiency
R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J;
Salo J; Medina E; Naranjo A; Esteller M; Pique JM
16
Cita
Gastroenterology; 2006 Dec; 131(6);
p. 1758-67
Gastroenterology; 2006 May; 130(6);
p. 1588-94
Hepatology (Baltimore, Md); 2006
Nov; 44(5); p. 1288-95
International journal of radiation
oncology, biology, physics; 2006 Oct
1; 66(2); p. 560-7
ournal of cerebral blood flow and
metabolism; 2006 Mar; 26(3); p. 42132
Hepatology (Baltimore, Md); 2006
Dec; 44(6); p. 1555-63
Hepatology (Baltimore, Md); 2006
Mar; 43(3); p. 485-91
Gastroenterologia y hepatologia; 2006
Oct; 29(8); p. 462-7
The journal of physical chemistry B,
Condensed matter, materials,
surfaces, interfaces & biophysical;
2006 Nov 30; 110(47); p. 24189-99
The Journal of rheumatology; 2006
Aug; 33(8); p. 1593-9
Gastroenterologia y hepatologia; 2006
Oct; 29(8); p. 467-521
Gastroenterologia y hepatologia; 2006
Feb; 29(2); p. 85-92
Clinical cancer research : an official
journal of the American Association for
Cancer Research; 2006 Mar 15; 12(6);
p. 1686-92
Daclizumab induction and
maintenance steroid-free
immunosuppression with
mycophenolate mofetil and
tacrolimus to prevent acute rejection
of hepatic allografts
Distinct cellular responses
differentiating alcohol- and hepatitis
C virus-induced liver cirrhosis
Docosahexaenoic acid (DHA) blunts
liver injury by conversion to
protective lipid mediators: protectin
D1 and 17S-hydroxy-DHA
Does silica surface catalyse peptide
bond formation? New insights from
first-principles calculations
Figueras J; Prieto M; Bernardos A; Rimola A;
Transplant international : official
Suarez F; de Urbina JO; Cuervas-Mons V; Mata Mde journal of the European Society for
L
Organ Transplantation; 2006 Aug;
19(8); p. 641-8
Lederer SL; Walters KA; Proll S; Paeper B;
Robinzon S; Boix L; Fausto N; Bruix J; Katze MG
Virology journal; 2006 Nov 22; 3; p. 98
Gonzalez-Periz A; Planaguma A; Gronert K; Miquel The FASEB journal; 2006 Dec; 20(14);
R; Lopez-Parra M; Titos E; Horrillo R; Ferre N;
p. 2537-9
Deulofeu R; Arroyo V; Rodes J; Claria J
Rimola A; Tosoni S; Sodupe M; Ugliengo P
Chemphyschem : a European journal
of chemical physics and physical
chemistry; 2006 Jan 16; 7(1); p. 15763
Downregulation of KLF6 is an early Kremer-Tal S; Narla G; Chen Y; Hod E; Difeo A; Yea Journal of hepatology; 2006 Nov 27
event in hepatocarcinogenesis, and S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M;
stimulates proliferation while
Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J;
reducing differentiation
Martignetti JA; Llovet JM; Friedman SL
Effects of propranolol on venous
Andreu V; Garcia-Pagan JC; Lionetti R; Piera C;
Journal of hepatology; 2006 Jun;
compliance in conscious rats with Abraldes JG; Bosch J
44(6); p. 1040-5
pre-hepatic portal hypertension
Effects of splenic artery occlusion Luca A; Miraglia R; Caruso S; Milazzo M; Gidelli B; Liver transplantation; 2006 Aug; 12(8);
on portal pressure in patients with Bosch J
p. 1237-43
cirrhosis and portal hypertension
Endoscopic ultrasonography in
Gines A; Pellise M; Fernandez-Esparrach G; Soria The American journal of
patients with large gastric folds at MT; Mata A; Membrillo A; Martinez-Palli G; Sole MM; gastroenterology; 2006 Jan; 101(1); p.
endoscopy and biopsies negative Llach J; Bordas JM; Pique JM
64-9
for malignancy: predictors of
malignant disease and clinical
impact
Excellent long-term survival in
Pares A; Caballeria L; Rodes J
Gastroenterology; 2006 Mar; 130(3);
patients with primary biliary cirrhosis
p. 715-20
and biochemical response to
ursodeoxycholic Acid
Expanded criteria for hepatocellular Llovet JM; Schwartz M; Fuster J; Bruix J
Seminars in liver disease; 2006 Aug;
carcinoma through down-staging
26(3); p. 248-53
prior to liver transplantation: not yet
there
Gene expression profiling of renal Lopez-Parra M; Telleria N; Titos E; Planaguma A;
Journal of hepatology; 2006 Aug;
dysfunction in rats with
Gonzalez-Periz A; Arroyo V; Rodes J; Claria J
45(2); p. 221-9
experimental cirrhosis
Heme oxygenase attenuates
Angermayr B; Mejias M; Gracia-Sancho J; Garcia- Journal of hepatology; 2006 Jun;
oxidative stress and inflammation, Pagan JC; Bosch J; Fernandez M
44(6); p. 1033-9
and increases VEGF expression in
portal hypertensive rats
Hepatic vein pressure gradient
D'Amico G; Garcia-Pagan JC, Luca A; Bosch J
Gastroenterology; 2006;131:1611-24
reduction and prevention of variceal
bleeding in cirrhosis: A systematic
review
Hepatic venous pressure gradient Blasco A; Forns X; Carrion JA; Garcia-Pagan JC;
Hepatology (Baltimore, Md); 2006
identifies patients at risk of severe Gilabert R; Rimola A; Miquel R; Bruguera M; Garcia- Mar; 43(3); p. 492-9
hepatitis C recurrence after liver
Valdecasas JC; Bosch J; Navasa M
transplantation
17
Hepatitis B vaccine and multiple
Salleras L; Bruguera M; Prat A
sclerosis: an unproved association
Hepatocarcinoma and HCV
Forner A; Varela M; Bruix J
Hepatocellular carcinoma in the
setting of liver transplantation
How ischaemic preconditioning
protects small liver grafts
Hyponatremia impairs early
posttransplantation outcome in
patients with cirrhosis undergoing
liver transplantation
Hyponatremia in cirrhosis: clinical
features and management
Medicina clinica; 2006 Apr 22;
126(15); p. 581-8
Gastroenterologia y hepatologia; 2006
Oct; 29 Suppl 2; p. 196-9
Varela M; Sanchez W; Bruix J; Gores GJ
Liver transplantation; 2006 Jul; 12(7);
p. 1028-36
Franco-Gou R; Rosello-Catafau J; Casillas-Ramirez The Journal of pathology; 2006 Jan;
A; Massip-Salcedo M; Rimola A; Calvo N; Bartrons 208(1); p. 62-73
R; Peralta C
Londono MC; Guevara M; Rimola A; Navasa M;
Gastroenterology; 2006 Apr; 130(4); p.
Taura P; Mas A; Garcia-Valdecasas JC; Arroyo V; 1135-43
Gines P
Martin-Llahi M; Guevara M; Gines P
Gastroenterologie clinique et
biologique; 2006 Oct; 30(10); p. 114451
Hyponatremia in cirrhosis: Results Angeli P; Wong F; Watson H; Gines P
Hepatology (Baltimore, Md); 2006
of a patient population survey
Dec; 44(6); p. 1535-42
Impact of upper digestive symptoms Balboa A; Mearin F; Badia X; Benavent J; Caballero European journal of gastroenterology
in patients with irritable bowel
AM; Dominguez-Munoz JE; Garrigues V; Pique JM; & hepatology; 2006 Dec; 18(12); p.
syndrome
Roset M; Cucala M; Figueras M
1271-7
Impaired extracellular matrix
Fernandez-Varo G; Morales-Ruiz M; Ros J; Tugues Journal of hepatology; 2007 Mar;
degradation in aortic vessels of
S; Munoz-Luque J; Casals G; Arroyo V; Rodes J;
46(3); p. 440-446
cirrhotic rats
Jimenez W;
Influence of beta-2 adrenergic
Turnes J; Hernandez-Guerra M; Abraldes JG; Bellot Hepatology (Baltimore, Md); 2006 Jan;
receptor gene polymorphism on the P; Oliva R; Garcia-Pagan JC; Bosch J
43(1); p. 34-41
hemodynamic response to
propranolol in patients with cirrhosis
Interaction of glycine with isolated Rimola A; Sodupe M; Tosoni S; Civalleri B;
Langmuir : the ACS journal of surfaces
hydroxyl groups at the silica
Ugliengo P
and colloids; 2006 Jul 18; 22(15); p.
surface: first principles B3LYP
6593-604
periodic simulation
Irritable intestine syndrome: a
Pique JM; Lanas A
Atencion primaria / Sociedad
disease with a high social,
Espanola de Medicina de Familia y
economic, and health-service load
Comunitaria; 2006 Jun 30; 38(2); p.
69-71
Is microbubble-enhanced
Vilana R; Bianchi L; Varela M; Nicolau C; Sanchez European radiology; 2006 Nov;
ultrasonography sufficient for
M; Ayuso C; Garcia M; Sala M; Llovet JM; Bruix J; 16(11); p. 2454-62
assessment of response to
Bru C
percutaneous treatment in patients
with early hepatocellular
carcinoma?
Ischemia-reperfusion syndrome
Casillas-Ramirez A; Mosbah IB; Franco-Gou R;
Gastroenterologia y hepatologia; 2006
associated with liver transplantation: Rimola A; Rosello-Catafau J; Peralta C
May; 29(5); p. 306-13
an update
Lactobacillus casei prevents the
Angulo S; Llopis M; Antolin M; Gironella M; Sans M; American journal of physiology
upregulation of ICAM-1 expression Malagelada JR; Pique JM; Guarner F; Panes J
Gastrointestinal and liver physiology;
and leukocyte recruitment in
2006 Dec; 291(6); p. G1155-62
experimental colitis
Life events and inflammatory bowel Vidal A; Gomez-Gil E; Sans M; Portella MJ;
The American journal of
disease relapse: a prospective
Salamero M; Pique JM; Panes J
gastroenterology; 2006 Apr; 101(4); p.
study of patients enrolled in
775-81
remission
Management of ascites and hepatic Cardenas A; Arroyo V
Best practice & research Clinical
hydrothorax
gastroenterology; 2007; 21(1); p. 5575
18
Management of gut ischemia
Pique JM
Microbiologic features and outcome
of pneumonia in transplanted
patients
Noncirrhotic portal vein thrombosis
exhibits neuropsychological and MR
changes consistent with minimal
hepatic encephalopathy
Norepinephrine induces calcium
spikes and proinflammatory actions
in human hepatic stellate cells
Norfloxacin vs ceftriaxone in the
prophylaxis of infections in patients
with advanced cirrhosis and
hemorrhage
Pharmacological reduction of portal
pressure and long-term risk of first
variceal bleeding in patients with
cirrhosis
Postoperative surveillance in
patients with colorectal cancer who
have undergone curative resection:
a prospective, multicenter,
randomized, controlled trial
Predictive factors of irritable bowel
syndrome improvement: 1-year
prospective evaluation in 400
patients
Prevalence of gastro-oesophageal
reflux disease in Spain and
associated factors
Prevention of viral hepatitis
Cervera C; Agusti C; Angeles Marcos M; Pumarola
T; Cofan F; Navasa M; Perez-Villa F; Torres A;
Moreno A
Minguez B; Garcia-Pagan JC; Bosch J; Turnes J;
Alonso J; Rovira A; Cordoba J
ndian journal of gastroenterology;
2006 Nov; 25 Suppl; p. S39-42
Diagnostic microbiology and infectious
disease; 2006 May; 55(1); p. 47-54
Hepatology (Baltimore, Md); 2006 Apr;
43(4); p. 707-14
Sancho-Bru P; Bataller R; Colmenero J; Gasull X;
Moreno M; Arroyo V; Brenner DA; Gines P
American journal of physiology
Gastrointestinal and liver physiology;
2006 Nov; 291(5); p. G877-84
Fernandez J; Ruiz del Arbol L; Gomez C; Durandez Gastroenterology; 2006 Oct; 131(4); p.
R; Serradilla R; Guarner C; Planas R; Arroyo V;
1049-56; quiz 1285
Navasa M
Turnes J; Garcia-Pagan JC; Abraldes JG;
Hernandez-Guerra M; Dell'Era A; Bosch J
The American journal of
gastroenterology; 2006 Mar; 101(3); p.
506-12
Rodriguez-Moranta F; Salo J; Arcusa A; Boadas J;
Pinol V; Bessa X; Batiste-Alentorn E; Lacy AM;
Delgado S; Maurel J; Pique JM; Castells A
Journal of clinical oncology; 2006 Jan
20; 24(3); p. 386-93
Mearin F; Badia X; Balboa A; Benavent J; Caballero Alimentary pharmacology &
AM; Dominguez-Munoz E; Garrigues V; Pique JM; therapeutics; 2006 Mar 15; 23(6); p.
Roset M; Cucala M; Figueras M
815-26
Ponce J; Vegazo O; Beltran B; Jimenez J; Zapardiel Alimentary pharmacology &
J; Calle D; Pique JM
therapeutics; 2006 Jan 1; 23(1); p.
175-84
Bruguera M
Enfermedades infecciosas y
microbiologia clinica; 2006 Dec;
24(10); p. 649-56
Prospective assessment of the role Llach J; Bordas JM; Almela M; Pellise M; Mata A;
Hepato-gastroenterology; 2006 Julof antibiotic prophylaxis in ERCP
Soria M; Fernandez-Esparrach G; Gines A; Elizalde Aug; 53(70); p. 540-2
JI; Feu F; Pique JM
Purification of recombinant
Camprubi S; Bruguera M; Canalias F
International journal of biological
histidine-tag streptolysin O using
macromolecules; 2006 Mar 30; 38(2);
immobilized metal affinity expanded
p. 134-9
bed adsorption (IMA-EBA)
Resistin as an intrahepatic cytokine: Bertolani C; Sancho-Bru P; Failli P; Bataller R; Aleffi The American journal of pathology;
overexpression during chronic injury S; DeFranco R; Mazzinghi B; Romagnani P; Milani 2006 Dec; 169(6); p. 2042-53
and induction of proinflammatory
S; Gines P; Colmenero J; Parola M; Gelmini S;
actions in hepatic stellate cells
Tarquini R; Laffi G; Pinzani M; Marra F
Risk assessment in relatives of
Ignasi Elizalde J; Pique JM
European journal of gastroenterology
gastric cancer patients:
& hepatology; 2006 Aug; 18(8); p.
hyperproliferation, genetics, and
877-9
Helicobacter pylori infection
Risk of upper gastrointestinal ulcer Lanas A; Garcia-Rodriguez LA; Arroyo MT;
Gut; 2006 Dec; 55(12); p. 1731-8
bleeding associated with selective Gomollon F; Feu F; Gonzalez-Perez A; Zapata E;
cyclo-oxygenase-2 inhibitors,
Bastida G; Rodrigo L; Santolaria S; Guell M; de
traditional non-aspirin non-steroidal Argila CM; Quintero E; Borda F; Pique JM
anti-inflammatory drugs, aspirin and
combinations
19
Sequential determination of
pharmacokinetics and
pharmacodynamics of
mycophenolic acid in liver transplant
patients treated with mycophenolate
mofetil
Sustained low diffusing capacity in
hepatopulmonary syndrome after
liver transplantation
Systemic hemodynamics,
vasoactive systems, and plasma
volume in patients with severe
Budd-Chiari syndrome
The eNOS cofactor
tetrahydrobiopterin improves
endothelial dysfunction in livers of
rats with CCl4 cirrhosis
The prevalence of HFE C282Y
gene mutation is increased in
Spanish patients with porphyria
cutanea tarda without hepatitis C
virus infection
TNF-alpha blockade downregulates the CD40/CD40L pathway
in the mucosal microcirculation: a
novel anti-inflammatory mechanism
of infliximab in Crohn's disease
Transient elastography for
diagnosis of advanced fibrosis and
portal hypertension in patients with
hepatitis C recurrence after liver
transplantation
Wilson's disease
Brunet M; Cirera I; Martorell J; Vidal E; Millan O;
Jimenez O; Rojo I; Londono MC; Rimola A
Transplantation; 2006 Feb 27; 81(4);
p. 541-6
Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; World journal of gastroenterology :
Roca J; Rodriguez-Roisin R; Burgos F; Gistau C
WJG; 2006 Sep 28; 12(36); p. 587883
Hernandez-Guerra M; Lopez E; Bellot P; Piera C;
Hepatology (Baltimore, Md); 2006 Jan;
Turnes J; Abraldes JG; Bosch J; Garcia-Pagan JC 43(1); p. 27-33
Matei V; Rodriguez-Vilarrupla A; Deulofeu R;
Colomer D; Fernandez M; Bosch J; Garcia-Pagan
JC
Hepatology (Baltimore, Md); 2006 Jul;
44(1); p. 44-52
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C;
Ercilla MG
Journal of the European Academy of
Dermatology and Venereology :
JEADV; 2006 Nov; 20(10); p. 1201-6
Danese S; Sans M; Scaldaferri F; Sgambato A;
Rutella S; Cittadini A; Pique JM; Panes J; Katz JA;
Gasbarrini A; Fiocchi C
Journal of immunology (Baltimore, Md
: 1950); 2006 Feb 15; 176(4); p. 261724
Carrion JA; Navasa M; Bosch J; Bruguera M;
Gilabert R; Forns X
Liver transplantation; 2006 Dec;
12(12); p. 1791-8
Bruguera M
Gastroenterologia y hepatologia; 2006
Jan; 29(1); p. 29-33
Revisió
Cavernous hemangioma
Bruguera M
Hepatitis C in Spain
Bruguera M; Forns X
Hepatorenal syndrome
Cardenas A; Gines P
Hyponatremia in cirrhosis: clinical
features and management
Management of end stage liver
disease (ESLD): what is the current
role of orthotopic liver
transplantation (OLT)?
Measurement of portal pressure
and its role in the management of
chronic liver disease
New aspects of diagnosis and
therapy of hepatocellular carcinoma
New treatments of hepatorenal
syndrome
Predictions from a hard liver
Martin-Llahi; Guevara M, GInez P
Gastroenterologia y hepatologia; 2006
Aug-Sep; 29(7); p. 428-30
Medicina clinica; 2006 Jun 17; 127(3);
p. 113-7
Clinics in liver disease; 2006 May;
10(2); p. 371-85, ix-x
Gastroenterol Clin Biol 2006;30:114451
Journal of hepatology; 2006; 44(1
Suppl); p. S140-5
Miro JM; Laguno M; Moreno A; Rimola A
Bosch J; Garcia-Pagan JC; Berzigotti A; Abraldes
JG
Seminars in liver disease; 2006 Nov;
26(4); p. 348-62
Bruix J; Hessheimer AJ; Forner A; Boix L; Vilana R; Oncogene; 2006 Jun 26; 25(27); p.
Llovet JM
3848-56
Arroyo V; Terra C; Gines P
Seminars in liver disease; 2006 Aug;
26(3); p. 254-64
Bosch J
Journal of hepatology; 2006 Aug;
45(2); p. 230-5
20
Therapy insight: Management of
hepatorenal syndrome
Cardenas A; Gines P
Treatment of hepatocellular
carcinoma
Forner A; Hessheimer AJ; Isabel Real M; Bruix J
Cas Clínic
Multifocal avascular necrosis after
liver transplantation: an unusual
presentation of the antiphospholipid
syndrome
Editorial
A brief dictionary of eponyms used
in gastroenterology
Diagnosis and staging of
hepatocellular carcinoma prior to
transplantation: expertise or failure
Hepatocellular carcinoma in the
United States. Lessons from a
population-based study in Medicare
recipients
Presentation
Mundo J; Peris P; Monegal A; Navasa M; Cervera R; Lupus; 2006; 15(5); p. 304-7
Guaniabens N
Bruguera M
Gastroenterologia y hepatologia; 2006
Mar; 29(3); p. 125-30
Liver transplantation; 2006 Oct;
12(10); p. 1445-7
Varela M; Forner A; Bruix J
Varela M; Bruix J
Journal of hepatology; 2006 Jan;
44(1); p. 8-10
Arroyo V
Gastroenterologia y hepatologia; 2006
Oct; 29 Suppl 2; p. 1
Gastroenterologia y hepatologia; 2006
Jun-Jul; 29(6); p. 349-51
Unmet needs in the approach to
irritable bowel syndrome
Carta
Feasibility and safety of pancreatic
islet transplantation in the liver by
portal vein catheterization using the
transjugular route
Is oral ciclosporin necessary to
switch from i.v. to thiopurines?
Pique JM; Lanas A
Transmission of HIV-1 from an
obstetrician to a patient during a
caesarean section
Capítul llibre
Ascites and spontaneous bacterial
peritonitis
Mallolas J; Gatell JM; Bruguera M
Conget I; Piquer S; Julia M; Gomis R; Esmatjes E;
Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ;
Fernandez-Cruz L; Manyalich M
Transplantation; 2006 Apr 27; 81(8); p.
1220-1
Domenech E; Gomollon F; Obrador A; Panes J;
Gassull MA
Alimentary pharmacology &
therapeutics; 2006 Feb 15; 23(4); 5556; author reply 556-7
AIDS (London, England); 2006 Aug
22; 20(13); p. 1785
Cárdenas A, Ginès P, Rodés J
Complications of Cirrhosis: Ascites, Cárdenas A, Ginès P, Arroyo V, Rodés J
Hyponatremia, Hepatorenal
Syndrome, and Spontaneous
Bacterial Peritonitis
Hemorragia digestiva por
García-Pagán JC, Bosch J.
hipertensión portal
Hepatocellular Carcinoma
Nature clinical practice
Gastroenterology & hepatology; 2006
Jun; 3(6); p. 338-48
Critical reviews in
oncology/hematology; 2006 Nov;
60(2); p. 89-98
J. Maurel , J. Bruix
21
En: Therapy of Digestive Disorders 2nd
Ed. Wolfe MM, Davis GL, Farraye F,
Giannella RA, Malagelada JR, Steer
ML. Eds. Saunders 2006, 607-18
In:
Comprehensive
Clinical
Hepatology, 2nd Ed. O’Grady J and
Bacon B Eds. Mosby. 2006, 153-168.
En: Problemas comunes en la práctica
clínica.
Gastroenterología
y
Hepatología.
Tomo
II
(MA.
Montoro)Jarpyo Editoreas SA Madrid
2006- ISBN (2 tomos):84-96549-26-7.
En : Hematology-Oncology Therapy.
Editor: Michael M. Boyiadzis, Peter F.
Lebowitz, James N. Frame, Tito
Fojo.2006: 179-182.
Hepatocellular Carcinoma
J. Bruix, C. Brú, JM. Llovet
Hepatoma
M. Varela, M. Sala, J. Bruix
Hepatorenal Syndrome
Arroyo V, Ginès P, Terra C, Torre A
Hepatorenal syndrome: current
concepts
Cardenas A, Ginès P
Hyponatremia: a risk factor of
hepatic encephalopathy in cirrosis
Guevara M, Ginès P
Prólogo
J. Bruix
Renal Dysfunction in Cirrhosis:
Arroyo V, Ginès P, Guevara M, Rodés J
Pathophysiology on Clinical Features
Treatment of the acute bleeding
episode
Laine L, Planas R, Nevens F, Bañares R, Patch D,
Bosch J
En: Hepatology, a textbook of liver
disease. Editor: Tomas D. Boyer,
Teresa L. Wright, Michael P. Manns.
Zakim and Boyer’s 2006. 1109 –
1131
En: Medical care of the Liver
Transplant Patient. Editor: Paul G.
Killenberg & Pierre-Alain Clavien,
2006: 119-138
En: Clinical critical care medicine.
Eds: Albert RK, Slutsky A, Ranieri M,
Takala J, Torres A. Mosby Elsevier.
489-96
Eds de Franchis R.
Portal
Hypertension IV- Procc. Of the Fourth
Baveno 2005. Blackwell. Oxford,
2006, 201-16.
EN: Hepatic encephalopathy and
nitrogen
metabolism.
Eds.
Häussinger D, Kirscheis G, Schlies F.
Springer 2006, 458-66.
En: Pathology of Hepatocellular
Carcinoma:
Editor:
Masamichi
Kokjiro. 2006
En: Zakim D, Boyer J (eds) 5th
Edition. Hepatology. A text book of
liver diseases. 2006, 417-52.
En:
Portal
Hypertension
IV.
Procedings of the Fourth Baveno
International COnsensus Workshop.
Ed: Roberto de Franchis. Ed:
Blackwell Publishing Ltd. Oxford,
2006. ISBN-13: 978-1-4051-3940-3.
IBC-10:1-4051-3940-4
Malalties de l'Aparell Digestiu - Projectes Finançats 2006
Inv. Principal
Ref. Ajut
Entitat
Arroyo V
00071
Agència de Gestió
Grup de Recerca en Hepatología Clínica
d’Ajuts Universitaris i de
Recerca (AGAUR) - SGR
Bosch J
PI 04/0655
Fondo Investigacion
Sanitaria
Hemodinámica hepática e hipertensión portal. Nuevos 174.225
desarrollos en la fisiopatología, evaluación no invasiva y
tratamiento
2004-2007
Bosch J
C03/02
Instituto de Salud Carlos
III
Red Nacional de Investigación en Hepatología y
Gastroenterología. Redes Temáticas de Investigación
Cooperativa
1.463.126
2003-2006
Instituto de Salud Carlos
III
CIBER de Enfermedades Hepáticas y Digestivas
(CIBEREHD). Área de hipertensión portal y
mecanismos de transición a cirrosis (Área 1)
5.120.000
2006
Bosch J
Nom Projecte
Import €
Durada
50.600
???
Bosch J
PI05/1285
FIS
Fisiopatología y nuevas formas de tratamiento de las
enfermedades hepáticas, gastroenterológicas y
pancreáticas
232.050
2005-2006
Bosch J
PI06/0623
FIS
Disfunción endotelial y actividad enos en la cirrosis.
Mecanismo, significación y nuevas aplicaciones
terapéuticas
289.795
2006
22
Bruix J
PI050150
FIS
Perfil de expresión génica en lesiones preneoplásicas y en
el carcinoma hepatocelular inicial, en la cirrosis por el virus
de la hepatitis C. Aplicación en la detección precoz y en el
diagnóstico
???
2006-2008
Gines P
PI050246
FIS
Complicaciones de la cirrosis en pacientes en
candidatos a trasplante hepático. Diseño de nuevas
estrategias para la reducción de la mortali8dad en lista
de espera de trasplante hepático
155.890
2005-2008
Gines P
SAF200501917
Dirección General de
Investigación
Efecto de la hiponatremia sobre la función
neuropsicológica en los pacientes con cirrosis.
Mecanismos patogénicos e intervenciones terapéuticas
71.400
???
Gines P
PI050246
FIS
Complicaciones de la cirrosis en pacientes en
candidatos a trasplante hepático. Diseño de nuevas
estrategias para la reducción de la mortalidad en lista
de espera de trasplante hepático.
155.890
2005-2008
Navasa M
PI050230
FIS
Evolución de la recidiva de la infección por el virus de la
hepatitis C en trasplante hepático de donante vivo.
Comparación con el trasplante convencional. Papel de
las lipoproteinas en la efectividad del virus de la
hepatitis C
46.410
2005-2008
Asociación Española de
Gastroenterología
Efectos de las variantes del gen CARD15/NOD2 sobre
los mecanismos de apoptosis
12.000
2004-2006
Panes J
Panes J
P/N: 503569
European Commission
for Research: The Sixth
Framework
Network of Excellence of European Molecular Imaging
Laboratories (EMIL)
84.530
2004-2007
Panes J
C03/02
Instituto Carlos III
Red Nacional de investigación en hepatología y
gastroenterología
126.000
2003-2006
Panes J
SAF200603074
Ministerio E y C.
Programa I+D
Análisis de expresión génica en la enfermedad
inflamatoria intestinal: relación con el fenotipo,
progresión de la enfermedad y respuesta al tratamiento
175.000
2006
Panes J
PSE-0100002006-6
Ministerio de E y C
Proyectos CientíficoTecnológicos Singulares
Desarrollo de un kit diganóstico para las enfermedades
inflamatorias mediadas por mecanismos inmunes
(IMID-Kit)
1.850.000
2006-2010
Malalties de l'Aparell Respiratori
Malalties de l'Aparell Respiratori - Publicacions 2006
Títol
Autors
Original
A new BAL fluid instillation and
Rosell A; Xaubet A; Agusti C; Castella J; Puzo C;
aspiration technique: a multicenter Curull V; de Gracia J
randomized study
A short course of oral prednisone Benitez P; Alobid I; de Haro J; Berenguer J; Bernalfollowed by intranasal budesonide is Sprekelsen M; Pujols L; Picado C; Mullol J
an effective treatment of severe
nasal polyps.
Addition of a macrolide to a ssDwyer R; Ortqvist A; Aufwerber E; Henriques
lactam in bacteremic pneumococcal Normark B; Marrie TJ; Mufson MA; Torres A;
pneumonia
Woodhead MA; Alenius M; Kalin M
Airway-centered interstitial fibrosis Serrano M; Molina-Molina M; Ramirez J; Sanchez M;
related to exposure to fumes from Xaubet A
cleaning products
Alexithymia: a relevant
Serrano J; Plaza V; Sureda B; de Pablo J; Picado C;
psychological variable in near-fatal Bardagi S; Lamela J; Sanchis J
asthma
23
Cita
Respiratory medicine; 2006 Mar;
100(3); p. 529-35
The Laryngoscope; 2006 May; 116(5);
p. 770-5
European journal of clinical
microbiology & infectious diseases;
2006 Aug; 25(8); p. 518-21
Archivos de bronconeumologia; 2006
Oct; 42(10); p. 557-9
The European respiratory journal;
2006 Aug; 28(2); p. 296-302
Alpha-1-Antitrypsin Deficiency:
Optimal Therapeutic Regime Based
On Population Pharmacokinetics
Association between habitual naps
and sleep apnea.
Barcelona Smell Test - 24 (BAST24): validation and smell
characteristics in the healthy
Spanish population
Bench Model To Simulate Upper
Airway Obstruction for Analyzing
Automatic Continuous Positive
Airway Pressure Devices
Changes in markers of epithelial
permeability and inflammation in
chronic smokers switching to a
nonburning tobacco device
(Eclipse)
Comparison of antimicrobial cycling
and mixing strategies in two medical
intensive care units
Control of ventilation,
breathlessness perception and
alexithymia in near-fatal asthma
Cryptic haplotypes of SERPINA1
confer susceptibility to chronic
obstructive pulmonary disease.
Depletes muscle glutathione in
patients with chronic obstructive
pulmonary disease and low body
mass index
Differences in COPD care among
doctors who control the disease:
General practitioner vs.
Pneumologist
Does Helicobacter pylori have a
pathogenic role in bronchiectasis?
Early Noninvasive Ventilation Averts
Extubation Failure in Patients at
Risk: A Randomized Trial
Effect of desloratadine on epithelial
cell granulocyte-macrophage
colony-stimulating factor secretion
and eosinophil survival
Effects of nebulized N(G)-nitro-Larginine methyl ester in patients
with hepatopulmonary syndrome
Etiología y factores pronósticos de
la neumonía adquirida en la
comunidad en el adulto
hospitalizado, Puerto Montt, Chile
Experimental safety and efficacy
evaluation of an extracorporeal
pumpless artificial lung in providing
respiratory support through the
axillary vessels
Soy D, de la Roza C, Lara B, Esquinas C, Torres A
Thorax, 2006; 61(12): 1059-64
Masa JF; Rubio M; Perez P; Mota M; de Cos JS;
Sleep; 2006 Nov 1; 29(11); p. 1463-8
Montserrat JM
Cardesin A; Alobid I; Benitez P; Sierra E; de Haro J; Rhinology; 2006 Mar; 44(1); p. 83-9
Bernal-Sprekelsen M; Picado C; Mullol J
Jordi Rigau, Josep M Montserrat, Holger Wöhrle,
Diana Plattner, et al
Chest. Chicago: Aug 2006.Vol. 130,
Iss. 2; pg. 350, 12 pgs
Stewart JC; Hyde RW; Boscia J; Chow MY; O'Mara Nicotine & tobacco research; 2006
RE; Perillo I; Pietropaoli A; Smith CJ; Torres A; Utell Dec; 8(6); p. 773-83
MJ; Frampton MW;
Martinez JA; Nicolas JM; Marco F; Horcajada JP;
Garcia-Segarra G; Trilla A; Codina C; Torres A;
Mensa J
Plaza V; Giner J; Picado C; Sureda B; Serrano J;
Casan P; Pablo JD; Sanchis J
Critical care medicine; 2006 Feb;
34(2); p. 329-36
Chappell S; Daly L; Morgan K; Guetta Baranes T;
Roca J; Rabinovich R; Millar A; Donnelly SC;
Keatings V; MacNee W; Stolk J; Hiemstra P; Miniati
M; Monti S; O'Connor CM; Kalsheker N
Rabinovich RA; Ardite E; Mayer AM; Polo MF; Vilaro
J; Argiles JM; Roca J
Human mutation; 2006 Jan; 27(1); p.
103-9
The Journal of asthma; 2006 Oct;
43(8); p. 639-44
Respiration; international review of
thoracic diseases; 2006; 73(6); p. 75761
García-Aymerich J, Escarrabill J, Marrades RM,
Resp Med, 2006. 100: 332-9
Monsó E, Barreiro E, Antó JM, EFRAM investigators
(Dr. A Torres como miembro del grupo)
Angrill J; Sanchez N; Agusti C; Guilemany JM;
Miquel R; Gomez J; Torres A
Ferrer M; Valencia M; Nicolas JM; Bernadich O;
Badia JR; Torres A
Respiratory medicine; 2006 Jul;
100(7); p. 1202-7
American journal of respiratory and
critical care medicine; 2006 Jan 15;
173(2); p. 164
Mullol J; Roca-Ferrer J; Alobid I; Pujols L; Valero A; Clinical and experimental allergy :
Xaubet A; Bernal-Sprekelsen M; Picado C
journal of the British Society for Allergy
and Clinical Immunology; 2006 Jan;
36(1); p. 52-8
Gomez FP; Barbera JA; Roca J; Burgos F; Gistau C; Hepatology (Baltimore, Md); 2006
Rodriguez-Roisin R
May; 43(5); p. 1084-91
Riquelme R, Riquelme M, Rioseco ML, Gómez V, Gil Rev Med Chile, 2006; 134: 597-605
R, Torres A
Iglesias M; Jungebluth P; Sibila O; Aldabo I; Matute The Journal of thoracic and
MP; Petit C; Torres A; Macchiarini P
cardiovascular surgery; 2007 Feb;
133(2); p. 339-45
24
Extravascular sources of lung
angiotensin peptide synthesis in
idiopathic pulmonary fibrosis
Fungal pneumonia, chronic
respiratory diseases and
glucocorticoids
Hospitalized Community-Acquired
Pneumonia Due to Streptococcus
pneumoniae*: Has Resistance to
Antibiotics Decreased?
Identification of Vascular Progenitor
Cells in Pulmonary Arteries of
Patients with Chronic Obstructive
Pulmonary Disease
Impact of Alcohol Abuse in the
Etiology and Severity of
Community-Acquired Pneumonia
Impact of initial antibiotic choice on
mortality from pneumococcal
pneumonia
Implications of COPD in patients
admitted to the intensive care unit
by community-acquired pneumonia
Influencia de las resistencias
bacterianas sobre la eficiencia del
tratamiento antibiótico de las
agudizaciones de la bronquitis
crónica en España
Integrated care prevents
hospitalisations for exacerbations in
COPD patients
Integrating hospitals into community
emergency preparedness planning
Is the incidence of near-fatal
asthma decreasing in Spain?
Li X; Molina-Molina M; Abdul-Hafez A; Ramirez J;
Serrano-Mollar A; Xaubet A; Uhal BD
Agusti C; Rano A; Aldabo I; Torres A
Valles X; Marcos A; Pinart M; Piner R; Marco F;
Mensa JM; Torres A
merican journal of physiology Lung
cellular and molecular physiology;
2006 Nov; 291(5); p. L887-95
Medical mycology; 2006 Sep; 44
Suppl; p. 207-11
Chest; 2006 Sep; 130(3); p. 800
Peinado VI; Ramirez J; Roca J; Rodriguez-Roisin R; American journal of respiratory cell
Barbera JA
and molecular biology; 2006 Mar;
34(3); p. 257-63
de Roux A; Cavalcanti M; Marcos MA; Garcia E;
Ewig S; Mensa J; Torres A
Chest; 2006 May; 129(5); p. 1219
Aspa J; Rajas O; Rodriguez de Castro F; Huertas
MC; Borderias L; Cabello FJ; Tabara J; HernandezFlix S; Martinez-Sanchis A; Torres A
Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan
J; Garnacho-Montero J; de la Torre MV; Sirvent JM;
Bodi M
Sabés R, Segú JL, Puig-Junoy J, Torres A, Piñol C
The European respiratory journal;
2006 May; 27(5); p. 1010-9
Casas A; Troosters T; Garcia-Aymerich J; Roca J;
Hernandez C; Alonso A; del Pozo F; de Toledo P;
Anto JM; Rodriguez-Roisin R; Decramer M
Braun BI; Wineman NV; Finn NL; Barbera JA;
Schmaltz SP; Loeb JM
Bellido Casado J; Plaza V; Bardagi S; Cosano J;
Lopez Vina A; Martinez Moragon E; Rodriguez-Trigo
G; Picado C; Sanchis J
Losartan attenuates bleomycin
Molina-Molina M; Serrano-Mollar A; Bulbena O;
induced lung fibrosis by increasing Fernandez-Zabalegui L; Closa D; Marin-Arguedas A;
prostaglandin E2 synthesis
Torrego A; Mullol J; Picado C; Xaubet A
Microbiologic features and outcome Cervera C; Agusti C; Angeles Marcos M; Pumarola
of pneumonia in transplanted
T; Cofan F; Navasa M; Perez-Villa F; Torres A;
patients
Moreno A
Mitochondrial dysfunction in copd Rabinovich RA; Bastos R; Ardite E; Llinas L;
patients with low body mass index Orozco-Levi M; Gea J; Vilaro J; Barbera JA;
Rodriguez-Roisin R; Fernandez-Checa JC; Roca J
Mixed community-acquired
de Roux A; Ewig S; Garcia E; Marcos MA; Mensa J;
pneumonia in hospitalised patients Lode H; Torres A
Mucin genes have different
Martinez-Anton A; Debolos C; Garrido M; Rocaexpression patterns in healthy and Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C;
diseased upper airway mucosa
Mullol J
Nonspecific interstitial pneumonia: Reyes LJ; Morell F; Xaubet A; Ramirez J; Majo J
epidemiologic and clinical
characteristics
Performance of mechanical
Farre R; Navajas D; Prats E; Marti S; Guell R;
ventilators at the patient's home: a Montserrat JM; Tebe C; Escarrabill J
multicentre quality control study
The European respiratory journal;
2006 Jul; 28(1); p. 123-30
25
The European respiratory journal;
2006 Jun; 27(6); p. 1210-6
Pharmacoeconomics, 2006; 3 (3):
109-122
Annals of internal medicine; 2006 Jun
6; 144(11); p. 799
Archivos de bronconeumologia; 2006
Oct; 42(10); p. 522-5
Thorax; 2006 Jul; 61(7); p. 604-10
Diagnostic microbiology and infectious
disease; 2006 May; 55(1); p. 47-54
The European respiratory journal;
2006 Dec 20
The European respiratory journal;
2006 Apr; 27(4); p. 795-800
Clinical and experimental allergy; 2006
Apr; 36(4); p. 448-57
Medicina clinica; 2006 Jan 21; 126(2);
p. 47-52
Thorax; 2006 May; 61(5); p. 400-4
Pulmonary endarterectomy for
Macchiarini P; Kamiya H; Hagl C; Winterhalter M;
chronic thromboembolic pulmonary Barbera JA; Karck M; Pomar J; Haverich A
hypertension: is deep hypothermia
required?
Quantifying plasma levels of
transforming growth factor beta1 in
idiopathic pulmonary fibrosis]
Recommendations for the use of
equations to estimate glomerular
filtration rate in adults. Spanish
Society of Nephrology
Relation between rhinosinusitis and
bronchiectasis
Risk and prognostic factors of
ventilator-associated pneumonia in
trauma patients
Severe nasal polyposis and its
impact on quality of life. The effect
of a short course of oral steroids
followed by long-term intranasal
steroid treatment
Sustained low diffusing capacity in
hepatopulmonary syndrome after
liver transplantation
Systemic effects of cigarette smoke
exposure in the guinea pig
Telemedicine experience for chronic
care in COPD.
Molina-Molina M; Lario S; Luburich P; Ramirez J;
Carrion MT; Xaubet A
European journal of cardio-thoracic
surgery : official journal of the
European Association for Cardiothoracic Surgery; 2006 Aug; 30(2); p.
237-41; discussion 241-3
Archivos de bronconeumologia; 2006
Aug; 42(8); p. 380-3
Gracia S; Montanes R; Bover J; Cases A; Deulofeu Nefrologia; 2006; 26(6); p. 658-65
R; Martin de Francisco AL; Orte LM
Guilemany JM; Mullol J; Picado C
Cavalcanti M; Ferrer M; Ferrer R; Morforte R;
Garnacho A; Torres A
Archivos de bronconeumologia; 2006
Mar; 42(3); p. 135-40
Critical care medicine; 2006 Apr;
34(4); p. 1067-72
Alobid I; Benitez P; Pujols L; Maldonado M; Bernal- Rhinology; 2006 Mar; 44(1); p. 8-13
Sprekelsen M; Morello A; Picado C; Mullol J
Martinez-Palli G; Gomez FP; Barbera JA; Navasa M; World journal of gastroenterology :
Roca J; Rodriguez-Roisin R; Burgos F; Gistau C
WJG; 2006 Sep 28; 12(36); p. 587883
Ardite E; Peinado VI; Rabinovich RA; FernandezRespiratory medicine; 2006 Jul;
Checa JC; Roca J; Barbera JA
100(7); p. 1186-94
de Toledo P; Jimenez S; del Pozo F; Roca J; Alonso IEEE transactions on information
A; Hernandez C
technology in biomedicine : a
publication of the IEEE Engineering in
Medicine and Biology Society; 2006
Jul; 10(3); p. 567-73
The impact of atopy, sinus
Alobid I; Benitez P; Valero A; Berenguer J; Bernal- Otolaryngology--head and neck
opacification, and nasal patency on Sprekelsen M; Picado C; Mullol J
surgery; 2006 Apr; 134(4); p. 609-12
quality of life in patients with severe
nasal polyposis
The impact of bronchiectasis
Guilemany JM; Alobid I; Angrill J; Ballesteros F;
Respiratory medicine; 2006 Nov;
associated to sinonasal disease on Bernal-Sprekelsen M; Picado C; Mullol J
100(11); p. 1997-2003
quality of life
The role of viruses in the aetiology Angeles Marcos M; Camps M; Pumarola T; Antonio Antiviral therapy; 2006; 11(3); p. 351-9
of community-acquired pneumonia Martinez J; Martinez E; Mensa J; Garcia E;
SFX
in adults
Penarroja G; Dambrava P; Casas I; Jimenez de Anta
MT; Torres A
Upregulation of COX-1 and COX-2 Roca-Ferrer J; Pujols L; Gartner S; Moreno A;
Thorax; 2006 Jul; 61(7); p. 592-6
in nasal polyps in cystic fibrosis
Pumarola F; Mullol J; Cobos N; Picado C
Revisió
A review of guidelines for
Blasi F; Ewig S; Torres A; Huchon G
Pulmonary pharmacology &
antibacterial use in acute
therapeutics; 2006; 19(5); p. 361-9
exacerbations of chronic bronchitis
ABS75: Asthma treatment in Spain - Cimas JE; Coira G; Lopez-Vina A; Sanchez CD;
Primary care respiratory journal :
Study in primary care and
Vegazo O; Picado C
journal of the General Practice
Pneumology Services
Airways Group; 2006 May 20;
Antibacterial dosage in intensive- Soy D, Torres A
Curr Opin Crit Care, 2006; 12 (5): 477care-unit patients based on
82
pharmacokinetic/ pharmacodynamic
principles
26
Antibiotic dosage regimens in
respiratory tract infections in the
pharmacokinetic /pharmacodynamic
era
Antibióticos en la exacerbación
aguda de la EPOC ¿Qué lugar
ocupa Cefditoren?
Antibiotics for exacerbations of
chronic obstructive pulmonary
disease
Associated inflammatory response
in pneumonia: role of adjunctive
therapy with glucocorticoids
Conducta y tratamiento en la
neumonía adquirida en la
comunidad
COPD exacerbations.5:
management
Formación troncal de las
especialidades médicas; Un reto del
presente para una mejora del
sistema sanitario
Soy D, Badia JR, Torres A
Current Respiratory Medicine
Reviews. 2006, 2: 89-7
Martínez P, Torres A
Med Clin Monogr, 2006, 7 (6): 327338
Ram FS; Rodriguez-Roisin R; Granados-Navarrete
A; Garcia-Aymerich J; Barnes NC
Cochrane database of systematic
reviews (Online); 2006 Apr 19; (2); p.
CD004403
Current opinion in infectious diseases;
2006 Apr; 19(2); p. 179-84
Rano A; Agusti C; Sibila O; Torres A
Martínez-Olondris P, Torres A
Jano, 2006; 1595: 43-6
Rodriguez-Roisin R
Thorax; 2006 Jun; 61(6); p. 535-44
Teres J, Capdevila JA, Nonell F, Cardellach F, Med Clin (Barc), 2006; 127 (4): 139-44
Bundó M, Torres M (Torres A, como miembro y
coautor de la Comisión de Medicina y
Especialidades Relacionadas dels Consell Català
d’Especialitats en Ciències de la Salut)
Intermediate Respiratory Care Units Ferrer M, Martínez P, Torres A
Clin Pulm Med, 2006; 13 (5): 1-7
Mechanisms of aspirin sensitivity
Picado C
Current allergy and asthma reports;
2006 May; 6(3); p. 198-202
Nosocomial pneumonia
Ostendorf U; Ewig S; Torres A
Current opinion in infectious diseases;
2006 Aug; 19(4); p. 327-38
Respiratory infections after lung
Belda J, Cavalcanti M, Iglesias M, Gimferrer, JM,
Clin Pulmonary Med, 2006; 13 (1): 8cancer resection
Torres A
16
Rupatadine: pharmacological profile Picado C
Expert opinion on pharmacotherapy;
and its use in the treatment of
2006 Oct; 7(14); p. 1989-2001
allergic disorders.
Surviving collapsed structure
Macintyre AG; Barbera JA; Smith ER
Prehospital and disaster medicine;
entrapment after earthquakes: a
2006 Jan-Feb; 21(1); p. 4-17;
"time-to-rescue" analysis
discussion 18-9
Tratamiento antimicrobiano de la
Torres A, Quintano JA, Martínez M, Rodríguez C,
Rev Esp Geriatr Gerontol, 2006; 41(6):
enfermedad pulmonar obstructiva Prieto J, Zalacaín R
362-77
crónica en el anciano
Tratamiento antimicrobiano de la
Torres A, Quintano JA, Martínez M, Rodríguez C,
Arch Bronconeumol, 2006; 42 (3): 1enfermedad pulmonar obstructiva Prieto J, Zalacaín R
15
crónica en el anciano
Tratamiento antimicrobiano de la
Torres A, Quintano JA, Martínez M, Rodríguez C,
Rev Esp Quimioterap, 2006; 19 (2):
EPOC en el anciano
Prieto J, Zalacaín R
167-83
Treatment failure in patients with
Dominguez AA; Arango MV; Torres A
Seminars in respiratory and critical
ventilator-associated pneumonia
care medicine; 2006 Feb; 27(1); p.
104-14
Two decades of imipenem therapy Rodloff AC, Goldstein EJC, Torres A
J Antimicrobial Chemotherapy (JAC),
2006; 58(5): 916-29
Cas Clínic
Pulmonary varix inside a bulla
Sellares J; Santos S; Ballester E; Barbera JA
Archivos de bronconeumologia; 2006
Jan; 42(1); p. 39-41
Tuberculosis, ancylostomiasis and Rodriguez E; Delgado Y; Buges J; Bastida T; Torres Anales de medicina interna (Madrid,
eosinophilic pleural effusion
M
Spain : 1984); 2006 Jan; 23(1); p. 46-7
Editorial
27
Assessment of pneumonia severity:
a European perspective
Improving the care of COPD
patients - suggested action points
by the COPD exacerbations
taskforce for reducing the burden of
exacerbations of COPD
Mortality in COPD patients with
community-acquired pneumonia:
who is the third partner?
Respiratory infections after lung
cancer resection
The new American Thoracic
Society/Infectious Disease Society
of North America guidelines for the
management of hospital-acquired,
ventilator-associated and
healthcare-associated pneumonia:
a current view and new
complementary information
Llibre
¿Qué pacientes con neumonía
adquirida en la comunidad
debemos derivar al hospital para
valorar ingreso hospitalario?
Preguntas al experto sobre
enfermedades infecciosas
Casos Clínicos de residentes de
Neumología y Cirugía Torácica
2005-2006
Clinical Criticare Care Medicine
Ewig S; Torres A; Woodhead M
Interacción cardiopulmonar y
transporte gaseoso
Manual de auscultación pulmonar.
Imágenes y sonidos en neumología
Normativa sobre valoración del
riesgo quirúrgico en el carcinoma
broncogénico
Respiratorio y atención primaria
Barberà J.A.
Celli B; Cross S; Grossman R; Kardos P; Myrseth
SE; Rodriguez-Roisin R; Vestbo J
Torres A; Menendez R
The European respiratory journal;
2006 Aug; 28(2); p. 262-3
Torres A
Expert review of anti-infective therapy;
2006 Oct; 4(5); p. 717-20
Current opinion in critical care; 2006
Oct; 12(5); p. 444-5
Torres A
Torres A, Dambrava P
(1ª edición), 2006; 1: 99-106
ISBN: 84-690-0302-X
Álvarez-Sala JL, Torres A, Viejo JL
ISBN: 84-7989-400-8. S.A. de
Ediciones, Madrid (España), 2006
Albert R, Ranieri M, Takala J, Slutsky A, Torres A
ISBN-13: 978-0-323-02844-8 ISBN10: 0-323-02844-6 Editorial Elsevier
2006, Philadelphia, USA
Madrid: Sanitaria 2000, 2006.
Ferrer M, Torres A
Varela G., Barberà J.A., Cordovilla R., Duque J.L.,
López-Encuentra A., Puente L.
Torres A, Naberán K
ISBN:84-7877-428-9.Edikamed,
Barcelona, 2006
Barcelona: Doyma, 2006.
Depósito legal : B-950-06 JC
Ediciones Médicas, S.L.. Barcelona
(España), Vol 1:1, 2006
Barcelona: Permanyer, 2006.
Técnicas y procedimientos en
Barberà J.A., Valera J.L., eds.
hipertensión pulmonar. Manual
SEPAR de Procedimientos -10
Woodhead M Respiratory Infections Torres A, Ewig S, Mandell L
Capítol Llibre
¿Qué pacientes con neumonía
adquirida en la comunidad
debemos derivar al hospital para
valorar ingreso hospitalario?
The European respiratory journa; 2006
Jan; 27(1); p. 6-8
Primary care respiratory journal; 2006
Jun; 15(3); p. 139-42
ISBN-10: 0-340-81694-5 ISBN-13:
978-0-340-81694-3 Editorial: Hodder
Headline Group, 2006
Arnold,
London, 2006
Torres A, Dambrava P
Preguntas al experto sobre
enfermedades infecciosas (1ª
edición), 2006; 1: 99-106
ISBN: 84-690-0302-X. Depósito Legal:
M-35216-2006
28
Circulación pulmonar en la
insuficiencia respiratoria
Pizarro S., Peinado V.I., Barberà J.A.
Diagnostic approach in ventilatorassociated pneumonia
Alcon A, Fábregas N, Torres A
Distrés respiratorio del adulto
Sellarés J, Ferrer M, Torres A
Emergency treatment of
community-acquired pneumonia.
Valencia M, Sellares J, Torres A
Enfermedades intersticiales difusas. Xaubet A
Fiblosis pulmonary idiopática
Epidemiology of nosocomial
respiratory infection
Bauer T, Torres A
Estudio hemodinámico pulmonar y Valera J.L., Melgosa M.T., Barberà J.A.
prueba vasodilatadora aguda
Hipertensión pulmonar
Barberà JA
Interacciones entre intercambio
gaseoso pulmonar y periférico
Roca J
La proyección internacional de la
SEPAR
Rodríguez-Roisin R
La SEPAR del siglo XXI
Torres A
Neumonía adquirida en la
comunidad. Epidemiología,
Etiología. Clínica.
Torres A
En: De Lucas P., Güell R., Rodríguez
J.M., Antón A., eds. Tratado de
insuficiencia respiratoria. Madrid,
SEPAR, 2006; 49-58.
En: Respiratory Infections. Torres A,
Ewig S, Mandell L, Woodhead M
ISBN-10: 0-340-81694-5. ISBN-13:
978-0-340-81694-3
Editorial: Hodder Headline Group,
2006. Capítulo 41.
En: Tratado de insuficiencia
respiratoria. SEPAR. ISBN: 84-8473498-6
En: Respiratory Emergencies. Nava S,
Welte T. Hardback ISBN:1-904097-383. Paperback ISBN: 1-904097-42-1
ISSN: 1025-448x
European Respiratory Monograph.
2006; 36(11): 183-199
En: Medicina Respiratoria 2ª edición.
Ed. SEPAR. Editores: Martín P,
Ramos G, Sanchis J
Sección VIII Capitulo 54: 953-969
ISBN: 84-7885-401-0
En: Respiratory Infections. Torres A,
Ewig S, Mandell L, Woodhead M
ISBN-10: 0-340-81694-5. ISBN-13:
978-0-340-81694-3
Editorial: Hodder Headline Group,
2006. Capítulo 38
En: Barberà J.A., Valera J.L.,
eds.Técnicas y procedimientos en
hipertensión pulmonar. Manual
SEPAR de Procedimientos – 10.
Barcelona: Permanyer, 2006; 17-35.
En: Alvarez-Sala J.L., Celli B., Torres
A., eds. Enfermedades pulmonares
vasculares. Respiratory disease selfassessment program. Medical Trends,
2006; 3-8.
En: Barberà J.A., ed. Interacción
cardiopulmonar y transporte gaseoso.
Madrid: Sanitaria 2000, 2006. 63-81
En: Historia de la neumología y la
cirugía torácica españolas
En: Historia de la neumología y cirugía
torácica Española
Editor: JL Álvarez Sala
ISBN: 84-689-8759-X. Depósito Legal:
M-23374-2006
En: Medicina respiratoria, segunda
edición. P. Martín, G. Ramos, J.
Sanchis.
ISBN: 84-7885-401-0. Depósito Legal:
M-12702-2005
SEPAR. Aula medica, Barcelona,
2006; Capítulo 46.1: 817-830.
29
Neumonía intrahospitalaría
Torres A
En: Patología infecciosa respiratoria
Depósito Legal: B-48.989.2004. Ed.
Doyma Update, 2006
En: 2006 Yearbook of Intensive Care
and Emergency Medicine. Vincent JL.
ISBN: 3-540-30155-0.
Editorial Springer Verlag, Berlín
(Alemania), 2006. Páginas: 494-501
En: Encyclopedia of Respiratory
Medicine, 2006
En: 32 Simposio de Neumología.
Asma y EPOC. Burgos, 20-21 oct de
2006: 55-68
Depósito Legal: BU-428-2006. Editor:
J.L. Viejo Bañuelos
En: Estudio de la función respiratoria.
Ed. Sanitaria 2000. Pino JM, García F.
ISBN: 84-611-2158-9. Cap. 5: 131154.
Madrid, Sanitaria 2000, 2006; 83-116.
Non-invasive Ventilation for
Sellares J, Ferrer M, Torres A
Respiratory Failure after Extubation.
Nosocomial Pneumonia
Torres A, Valencia M, Sellarés J
Nuevos retos en el tratamiento Torres A
antibiótico de la Exacerbación de la
EPOC.
Pruebas de provocación nasal
Bartra J, Valero AL, Picado C
Regulación del tono vascular
pulmonar. En: Barberà J.A., ed.
Interacción cardiopulmonar y
transporte gaseoso
Tratamiento de las agudizaciones
de la EPOC
Tratamiento en las infecciones
respiratorias comunitarias.
Peinado V.I., Barberà J.A.
Soler L, Martinez P, Pizarro S, Torres A
Martínez-Olondris P, Pizarro S, Soler N, Torres A
Un nuevo paradigma: Utilidad
Torres A
potencial de los antibióticos en las
agudizaciones del asma. El estudio
Telicast.
Unidades de cuidados intermedios Ferrer M, Martinez-Olondris P, Torres A
respiratorios
Ventilator-Associated Pneumonia
Carta
The SERPINE2 gene and chronic
obstructive pulmonary disease
Torres A, Alcón A, Fabregas N
En: Infección 2004 Editores: Picazo
JJ, Bouza E
En: Antimicrobianos en medicina.
Prous Science. ISBN: 978-81-8124240-9
En: 32 Simposio de Neumología.
Asma y EPOC. Burgos, 20-21 oct de
2006: 101-106
Depósito Legal: BU-428-2006. Editor:
J.L. Viejo Bañuelos
En:
Tratado
de
insuficiencia
respiratoria Editores: Pilar de Lucas,
Rosa Güell, José Miguel Rodríguez,
Antonio Antón ISBN: 84-8473-498-6
En: Clinical Critical Care Medicine.
Albert RK, Slutsky A, Ranieri M,
Tácala J, Torres A
ISBN: 0-323-02844-6. Editorial
Elsevier, 2006. Capítulo 19. 175-186
Chappell S; Daly L; Morgan K; Baranes TG; Roca J; American journal of human genetics;
Rabinovich R; Millar A; Donnelly SC; Keatings V;
2006 Jul; 79(1); 184-6; author reply
MacNee W; Stolk J; Hiemstra PS; Miniati M; Monti S; 186-7
O'Connor CM; Kalsheker N
30
Malalties de l'Aparell Respiratori - Projectes de recerca finançats 2006
Inv. Principal
Ref. Ajut
Entitat
Títol
Import €
Barberà JA
PI041424
FIS
Bases moleculares y celulares del daño vascular,
140.875
pulmonar y sistémico, asociado a situaciones de hipoxia
continua o intermitente: implicaciones en la enfermedad
pulmonar obstructiva cr´`onica y el síndrome de apneas
durante el sueño.
2005-2007
Barberà JA
PI050244
FIS
Contribución de las celulas progenitoras vasculares en
los mecanismos de reparación y remodelado de la
circulación pulmonar en la enfermedad pulmonar
obstructiva crónica
164.220
2005-2008
Barberà JA
SLMM-CT2005-018725
Unió Europea
(6th FWP)
Pulmonary hipertensión: Functional genomics and
therapy of lung vascular remodelling
(PULMOTENSION)
315.677
2005-2009
Barberà JA
PI031685
FIS
Estudio epidemiológico de las repercusiones clínicas,
funcionales y biológicas de la exposición al vertido de
fuel del buque Prestige sobre la salud respiratoria en
marineros de la costa de Galicia
485.300
2003-2006
Barberà JA
040310
Fundació La Marató de
TV3
Estudi de la contribució de les cèl•lules progenitores
vasculars en els mecanismes de lesió i reparació
vascular a la circulació pulmonar en la malaltia
pulmonar obstructiva crònica (MPOC)
140.000
2005-2008
Picado C
PI050108
FIS
Estudio de la relación entre la intolerancia a los
antiinflamatorios no esteroideos y la producción de
PGE2 con la gravedad del asma
119.000
2005-2008
Roca J
PI050282
FIS
Nuevos modelos de prestación de servicios sanitarios
utilizando telemedicina
20.349
2005-2008
Roca J
C510866
Unió Europea. Healt
Telematics Program
SPEX (Spreading Excellence in healthcare)
124.636
2004-2006
Roca J
C510743
Unió Europea. Healt
Telematics Program
Ward in Hard
95.861
2004-2006
Roca J
508015
Unió Europea. Healt
Telematics Program
Doc@Hand(Knowledge sharing and decision support for 228.400
healthcare professionals)
2004-2006
Roca J
42010
La Marató de TV3
Atenció Integrada i biopatologia de la MPOC avançada
149.088
2005-2007
Roca J
517352
Unión Europea -eTEN
HealthService24 - Continuous Mobile services for
Healthcare
136.400
2005-2006
Roca J
517535
Unión Europea -eTEN
LINKCARE -Linking Health Professionals in Emerging
Care Environments
250.689
2005-2006
Roca J
017333
Unió Europea (6th FWP)
Careman (Healthcare by Biosensor Measurements and
Networking)
203.670
2005-2008
Roca J
PI061510
FIS
Entrenamiento muscular y actividad física en la EPOC
83.490
2006-2009
Roca J
C029402
Unión Europea - eTEN
Remote Health Monitoring with Wearable Non-Invasive
Mobile System (HealthWear)
142.812
2006-2008
Roca J
037939
Unión Europea – FP6
Integrative Genomics and Chronic Disease Phenotypes: 450.000
modelling and simulation tools for clinicians (BioBridge)
2006-2009
Torres A
PI050136
FIS
Modelo animal de neumonía asociada a la ventilación
mecánica (NAVM). Estudio de la respuesta inflamatoria
asociada y su modulación por glucocorticoides
121.618
2006-2009
Torres A
CB06/06/0028
Instituto de Salud Carlos
III
CIBER: enfermedades respiratorias
120.000
2006-2007
Torres A
??
FIS
Contratos de apoyo a la Investigación del Sistema 24.000
Nacional de Salud
2006-2009
Torres A
??
SEPAR
Modelo animal de neumonía asociada a la ventilación 18.000
mecánica (NAVM). Estudio de la respuesta inflamatoria
asociada y su modulación por glucocorticoides
2006
31
Durada
Malalties del Sistema Endocrí i de la nutrició
Malalties Sistema Endocrí i de la nutrició - Publicacions 2006
Títol
Autors
Original
A FoxO-Smad synexpression group Gomis RR; Alarcon C; He W; Wang Q; Seoane J;
in human keratinocytes
Lash A; Massague J
Análisis coste-utilidad de las
bombas de insulina frente a
múltiples dosis diarias de insulina
en pacientes con Diabetes tipo I en
España
Assessment and control of
metabolic and cardiovascular risk in
patients with schizophrenia
C/EBPbeta at the core of the
TGFbeta cytostatic response and its
evasion in metastatic breast cancer
cells.
Comparison of the effects of
continuous subcutaneous insulin
infusion (CSII) and NPH-based
multiple daily insulin injections
(MDI) on glycaemic control and
quality of life: results of the 5nations trial.
Correlated mutations: advances and
limitations. A study on fusion
proteins an on the CohesinDockerin families.
Effect of ramipril on the incidence of
diabetes
Effect of rosiglitazone on the
requency of diabetes in patients
with impaired glucose tolerance or
impaired fasting glucose: a
randomised controlled trial
Estrategias para un control eficaz
de la hipertensión arterial en
España. Documento de consenso.
GLP-1 and changes in glucose
tolerance following gastric bypass
surgery in morbidly obese subjects.
Hepatitis C virus and splenic
marginal zone lymphoma with
villous lymphocytes: Hawai from
conventional therapy.
Histone H3 lysine 4 dimethylation
signals the transcriptional
competence of the adiponectin
promoter in preadipocytes.
Conget I, Rodríguez JM, Levy I, Castell C, Roze S,
Serrano D
Rodriguez-Artalejo F; Baca E; Esmatjes E; MerinoTorres JF; Monereo S; Moreno B; Mories T; Roca M;
Salvador J; Sanmarti A
Gomis RR; Alarcon C; Nadal C; Van Poznak C;
Massague J
Cita
Proceedings of the National Academy
of Sciences of the United States of
America; 2006 Aug 22; 103(34); p.
12747-52
Rev. Esp. Salud Pública 2006;80:679695
Medicina clinica; 2006 Oct 14;
127(14); p. 542-8
Cancer cell; 2006 Sep; 10(3); p. 20314
Hoogma RP; Hammond PJ; Gomis R; Kerr D;
Diabetic medicine : a journal of the
Bruttomesso D; Bouter KP; Wiefels KJ; de la Calle British Diabetic Association; 2006 Feb;
H; Schweitzer DH; Pfohl M; Torlone E; Krinelke LG; 23(2); p. 141-7
Bolli GB
Halperin I, Wolfson H, Nussionov R.
Proteins. 2006 Jun 1;63(4):832-45.
The DREAM trial investigators (I Conget, Steering
Committee)
The DREAM trial investigators (I Conget, Steering
Committee)
N. Engl. J. Med. 2006;114:1551-62
Lancet 2006;368:1096-105
Coca A, Aranda P, Bertnomeu V, Bonet A, Esmatjes Semergen 2006;32(7):330-333.
E, Guillén F, Hernández J, Llisterri JL, Marín R,
Megía C, Rodríguez L.
Morinigo R; Lacy AM; Casamitjana R; Delgado S;
Obesity surgery : the official journal of
Gomis R; Vidal J
the American Society for Bariatric
Surgery and of the Obesity Surgery
Society of Australia and New Zealand;
2006 Dec; 16(12); p. 1594-601
Gurvits GE, Matan R, Halperin I.
Scand. J. Gastroenterol. 2007 Jul
20;1-2
Musri MM; Corominola H; Casamitjana R; Gomis R; The Journal of biological chemistry;
Parrizas M
2006 Jun 23; 281(25); p. 17180-8
32
Improving metabolic control in suboptimally controlled subjects wity
Type 1 diabetes: comparison of two
tretament algorithms using insulin
glargine.
Inhibition of GSK3 dependent tau
phosphorylation by metals
Intra-abdominal fat adiponectin
receptors expresión and
cardiovascular metabolic risk
factors in obesity and diabetes.
Intra-abdominal fat adiponectin
receptors expression and
cardiovascular metabolic risk
factors in obesity and diabetes
Gomis R, Storms F, Conget I, Sinnassamy P, Davies Diab. Res. Clin. Pract . 2006
M.
Nefropatía diabética: de la
hiperfiltración glomerular al
trasplante renal.
Prognostic significance of the white
coat hypertension in patients with
type 1 diabetes mellitus
Sodium tungstate decreases the
phosphorylation of tau through
GSK3 inactivation.
Strategies for effective control of
arterial hipertensión in Spain.
Consensus document
Esmatjes E.
Gomez-Ramos A; Dominguez J; Zafra D;
Current Alzheimer research; 2006 Apr;
Corominola H; Gomis R; Guinovart JJ; Avila J
3(2); p. 123-7
Morinigo R, Musri M, Vidal J, Casamitjana R,
Obes. Surg. 16(6):745-751
Delgado S, Laci AM, Ayuso C, Gomis R, Corominola
H.
Morinigo R; Musri M; Vidal J; Casamitjana R;
Delgado S; Lacy AM; Ayuso C; Gomis R;
Corominola H
Flores L; Gimenez M; Esmatjes E
Diabetes research and clinical
practice; 2006 Oct; 74(1); p. 21-5
Gomez-Ramos A; Dominguez J; Zafra D;
Corominola H; Gomis R; Guinovart JJ; Avila J
Journal of neuroscience research;
2006 Feb 1; 83(2); p. 264-73
Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes
E, Guillén F, Hernández-Moreno J, Llisterri JL,
Marín-Iranzo R, Megia C, Rodríguez-Manas L,
Suárez C.
Telecare in a structured therapeutic Jansa M; Vidal M; Viaplana J; Levy I; Conget I;
education programme addressed to Gomis R; Esmatjes E
patients with type 1 diabetes and
poor metabolic control
Telecare in a structured therapeutic Jansa M; Vidal M; Viaplana J; Levy I; Conget I;
education programme addressed to Gomis R; Esmatjes E
patients with type 1 diabetes and
poor metabolic control.
The logic of TGFbeta signaling
Massague J; Gomis R
Therapeutic educations seminars
for patines.
Rev. Clin. Esp. 2006 Nov; 2006(10):
510-4
Diabetes research and clinical
practice; 2006 Oct; 74(1); p. 26-32
2006 Oct; 74(1); p. 26-32
FEBS letters; 2006 May 22; 580(12);
p. 2811-20
Eur. Diabetes Nursing 2006:3:132136.
Vidal M, Jansà M, Levy I, Jiménez M, Herrera F,
Lorente I, Marín MC, Oriell J, Sanhonorato J, Sanz
O, Conget I.
Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez Medicina clinica; 2006 Feb 18; 126(6);
J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A p. 201-5
Treatment and control of
cardiovascular risk in primary care
in Spain. The PREVENCAT study
Young adult onset diabetes mellitus. Conget I; Gimenez M; Nicolau J; Costa A; Oriola J;
Clinical differences between MODY- Casamitjana R;
3 and type 2 diabetes mellitus
Revisió
Algoritmo terapéutico de la
Giménez M, Conget I.
Diabetes mellitus tipo 1.
Endocrine evaluation of patients
after brain injury: what else is
needed to define specific clinical
recommendations?
Obesity surgery : the official journal of
the American Society for Bariatric
Surgery and of the Obesity Surgery
Society of Australia and New Zealand;
2006 Jun; 16(6); p. 745-51
Avances en diabetología
2006;22(2):2-4.
Sesmilo G, Halperin I, Puig-Domingo M.
33
Medicina clinica; 2006 May 6; 126(17);
p. 651-2
Endocrinol. Nutr. 2006;53 (Supl. 2):46.
Hormones (Athens). 2007 AprJun;6(2):132-7.
La prevención de la diabetes
mellitus de tipo 2 ¿realidad o
sueño? A propósito de los
resultados del estudio DREAM.
Mild cognitive impairment (MCI):
characteristics, risk factors and
prevention
Síndrome metabólico. Definición y
epidemiología.
Carta
Feasibility and safety of pancreatic
islet transplantation in the liver by
portal vein catheterization using the
transjugular route
Llibre
La fi de la diabetes? Cèl.lules mare,
l’esperança de la biomedicina.
Conget I, Giménez M.
Av. Diabetol. 2006;22:112-114.
Halperin I, Korczyin AD
Harefuah. 2006 Mar;145(3):22934,243.
Giménez M, Nicolau J, Conget I.
Rev. Clin.Esp. 2006;206 (Supl. 1) 3-6.
Conget I; Piquer S; Julia M; Gomis R; Esmatjes E;
Garcia-Pagan JC; Bosch J; Gilabert R; Ricart MJ;
Fernandez-Cruz L; Manyalich M
Transplantation; 2006 Apr 27; 81(8); p.
1220-1
Gomis R.
Edicions Bromera-Publicacions Univ.
De Valencia-Càtedra de divulgació de
la Ciencia. Alzira, 2006.
Prediabetes y diabetes tipo 1 de
reciente diagnóstico.
Conget I. (Coordinador)
Biblioteca de la Sociedad Española de
Diabetes. Sociedad Española de
Diabetes-Ediciones Mayo. Barcelona,
2006.
Conget I.
En: Guía práctica para la prevención,
evaluación y tratamiento.J Viadé. Ed.
Panamericana. Madrid, 2006
Capítol Llibre
Prólogo. Pie diabético.
Malalties del Sistema Endocrí i de la Nutrició - Projectes Finançats 2006
Investigador Principal
Referència Ajut
Entitat
Nom Projecte
Import
Durada
Conget I
Ajut Contracte associat a Hospital
Sistemas de infusión subcutánea continua de insulina y de
projecte de recerca
Clínic i
monitorización continua de la glucosa en la Diabetes de Tipo 1. Efecto
Universitari sobre el perfil de riesgo cardiovascular de los pacientes con control
lábil por hipoglucemias recurrentes y severas.
24.000 2006-2009
Conget I
PI060250
FIS
Sistemas de infusión subcutánea continua de insulina y de
monitorización continua de la glucosa en la Dibetes de Tipo 1. Efecto
sobre el perfil de riesgo cardiovascular de los pacientes con control
lábil por hipoglucemias recurrentes y severas.
57.475 2006-2009
Esmatjes E
PI070124
FIS
Efectos del by-pass gástrico sobre la presión arterial y la disfunción
endotelial en personas con obesidad grave
44.770
Gomis R
CE503245-0
CEE
Coordination action on the aetiology, pathology and prediction of type
1 diabetes in Europa (TONECA)
32.957,60 2004 -2008
Gomis R
RD06/0015/00
FIS
REDIMET-Red de diabetes y enfermedades metabólicas asociadas
450.000 2007-2010
Gomis R
2005SGR00019
?
Diabetes i alteracions metabòliques. Investigació cel.lular i molecular
en diabetis i obesitat
50.600 2005-2008
Gomis R
Genoma_ES 06/409
?
Banco Nacional de ADN-Nodo de Metabólicas
212.677 2006-2009
Gomis R
PI042553
FIS
Efecto del tungstato sobre el síndrome metabólico: dianas moleculares
106.950 2005-2007
Gomis R
PI051264
FIS
Defectos moleculares en la diabetes mellitus: terapia genética y
celular.
41.769
2006
Gomis R
051241
FIS
Biocomunicación celular y redes moleculares en enfermedades
metabólicas
136.255
2006
Gomis R
SAF2006-07382
?
Dianas moleculares inducidas por tungstato en la obesidad
677.600 2006-2011
Gomis R
LSHM-CT-2004-503245
?
Coordinated action on the aetiology, pathology and prediction of type 1
diabetes in Europe (TONECA)
34
2006
33.500 2004-2008
Malalties del Sistema Excretor Renal i Genital Masculí
Malalties del Sistema Excretor Renal i Genital Masculí - Publicacions 2006
Títol
Autors
Original
Automedida de la presión arterial J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX
domiciliaria. Influencia del sistema Naberan, A. Botey
de cáculo de la media en el
diagnóstico de la Hipertensión de
bata blanca
Catastrophic antiphospholipid
Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S;
syndrome presenting with renal
Ramos-Casals M; Soler M; Torras A; Font J
thrombotic microangiopathy and
diffuse proliferative
glomerulonephritis
Conversion from calcineurin
Saurina A; Campistol JM; Piera C; Diekmann F;
inhibitors to sirolimus in chronic
Campos B; Campos N; de las Cuevas X;
allograft dysfunction: changes in
Oppenheimer F
glomerular haemodynamics and
proteinuria
Does losartan alter urinary levels of Campistol JM
connective tissue growth factor in
patients with diabetic nephropathy?
Gastrointestinal stromal tumors
Darnell A; Dalmau E; Pericay C; Musulen E; Martin
J; Puig J; Malet A; Saigi E; Rey M
Guidelines of the Spanish Society of Marin R; Goicoechea MA; Gorostidi M; Cases A;
Nephrology: the kidney and
Diez J; Escolar G; Fernandez-Vega F; Palomar R;
cardiovascular disease. Short
Rodrigo E; Martinez I; Segura J
version
Home blood presure self-monitoing: J. Bayó, FX Cos, C. Roca, A. Dalfó, MM Martíndiagnostic performance in whiteBaranera, A. Botey
coat hypertension
Implication of chromosome 18 in
Guzman B; Cormand B; Ribases M; Gonzalez-Nunez
hypertension by sibling pair and
D; Botey A; Poch E
association analyses: putative
involvement of the RKHD2 gene
Increase of proteinuria after
Ruiz JC; Campistol JM; Sanchez-Fructuoso A;
conversion from calcineurin inhibitor Rivera C; Oliver J; Ramos D; Campos B; Arias M;
to sirolimus-based treatment in
Diekmann F
kidney transplant patients with
chronic allograft dysfunction
Posttransplant diabetes mellitus in Marcen R; Morales JM; del Castillo D; Campistol
renal allograft recipients: A
JM; Seron D; Valdes F; Anaya F; Andres A; Arias M;
prospective multicenter study at 2 Bustamante J; Capdevila L; Escuin F; Gil-Vernet S;
years
Gonzalez-Molina M; Lampreave I; Oppenheimer F;
Pallardo L
Potential role of proliferation signal Andres V; Castro C; Campistol JM
inhibitors on atherosclerosis in renal
transplant patients
Prevalence, clinical correlates and Lorenzo V; Martin-Malo A; Perez-Garcia R;
therapy cost of mineral
Torregrosa JV; Vega N; de Francisco AL; Cases A
abnormalities among haemodialysis
patients: a cross-sectional
multicentre study
35
Cita
Aten Primaria 2006;38:212-8
Clinical and experimental
rheumatology; 2006 Jan-Feb; 24(1); p.
110
Nephrology, dialysis, transplantation;
21(2); p. 488-93
Nature clinical practice Nephrology;
2006 Apr; 2(4); p. 192-3
Abdominal imaging; 2006 Jul-Aug;
31(4); p. 387
Nefrologia; 2006; 26(1); p. 31-44
Blood Presure Monitoring 2006; 11:4752
Hypertension; 2006 Nov; 48(5); p.
883-91
Nephrology, dialysis, transplantation
2006 Nov; 21(11); p. 3252-7
Transplantation proceedings; 2006
Dec; 38(10); p. 3530-2
Nephrology, dialysis, transplantation:
2006 Jul; 21 Suppl 3; p. iii14-7
Nephrology, dialysis, transplantation;
2006 Feb; 21(2); p. 459-65
Sirolimus therapy after early
cyclosporine withdrawal reduces the
risk for cancer in adult renal
transplantation
Transrectal ultrasound-guided
prostate biopsy: is antibiotic
prophylaxis necessary?
Treatment of hepatitis C in
hemodialysis patients and renal
transplant recipients
Usefulness of 111In-oxine labelled
platelets in the management of
febrile syndrome in dialysis patients
with non-functional renal allografts
Revisió
Chronic transplant nephropathy
Cas Clínic
Renal cortical necrosis after kidney
transplantation associated with the
prothrombin 20210A mutation
Editorial
A year of advancement and
reflection in nephrology science
Conversion from calcineurin
inhibitors to sirolimus in chronic
allograft nephropathy: benefits and
risks
Campistol JM; Eris J; Oberbauer R; Friend P;
Hutchison B; Morales JM; Claesson K; Stallone G;
Russ G; Rostaing L; Kreis H; Burke JT; Brault Y;
Scarola JA; Neylan JF
Puig J; Darnell A; Bermudez P; Malet A; Serrate G;
Bare M; Prats J
Journal of the American Society of
Nephrology : JASN; 2006 Feb; 17(2);
p. 581-9
Barrera J; Campistol JM
Gastroenterologia y hepatologia; 2006
Oct; 29 Suppl 2; p. 158-62
European radiology; 2006 Apr; 16(4);
p. 939-43
Ortin-Perez J; Fuster D; Lomena F; Torregrosa JV; Revista espanola de medicina nuclear;
Piera C; Rodriguez-Puig D; Duch J; Rubi S; Setoain 2006 Sep; 25(5); p. 289-93
X; Campistol JM; Pons F
Hernandez D; Sanchez Fructuoso A; Seron D; Arias Nefrologia; 2006; 26 Suppl 1; p. 1-38
M; Campistol JM; Morales JM; Alonso A; Andres A;
del Castillo D; Gentil MA; Gonzalez-Molina M;
Gonzalez Posada JM; Moreso F; Oppenheimer F;
Pallardo LM; Sola R
Quintana LF; Cofan F; Reverte JC; Oppenheimer F; Nephrology, dialysis, transplantation;
Campistol JM
2006 May; 21(5); p. 1455-6
Cases A
Drug news & perspectives; 2006 Mar;
19(2); p. 121-7
Nephrology, dialysis, transplantation;
2006 Mar; 21(3); p. 562-8
Diekmann F; Campistol JM
Malalties del Sistema Nerviós
Malalties del Sistema Nerviós - Publicacions 2006
Títol
Autors
Original
123I-Ioflupane SPECT in the
Gaig C; Marti MJ; Tolosa E; Valldeoriola F; Paredes
diagnosis of suspected psychogenic P; Lomena FJ; Nakamae F
Parkinsonism
Anti-VCAM-1 antibodies did not
Justicia C; Martin A; Rojas S; Gironella M; Cervera
protect against ischemic damage
A; Panes J; Chamorro A; Planas AM
either in rats or in mice
Blood lead levels in children and
Gasana J; Hlaing WM; Siegel KA; Chamorro A;
environmental lead contamination in Niyonsenga T
Miami inner city, Florida
Characterization of a conduit
Drumea-Mirancea M; Wessels JT; Muller CA; Essl
system containing laminin-5 in the M; Eble JA; Tolosa E; Koch M; Reinhardt DP; Sixt
human thymus: a potential transport M; Sorokin L; Stierhof YD; Schwarz H; Klein G
system for small molecules
CLEAR-test: Combining inference Valls J; Grau M; Sole X; Hernandez P; Montaner D;
for differential expression and
Dopazo J; Peinado MA; Capella G; Moreno V;
variability in microarray data
Pujana MA
analysis
36
Cita
Movement disorders; 2006 Nov;
21(11); p. 1994-8
Journal of cerebral blood flow and
metabolism; 2006 Mar; 26(3); p. 42132
International journal of environmental
research and public health; 2006 Sep;
3(3); p. 228-34
Journal of cell science; 2006 Apr 1;
119(Pt 7); p. 1396-405
Journal of biomedical informatics;
2007 May 17
Clinical consequences of infection
in patients with acute stroke: is it
prime time for further antibiotic
trials?
Effect of glatiramer acetate
(Copaxone) on the
immunophenotypic and cytokine
profile and BDNF production in
multiple sclerosis: a longitudinal
study
EFNS Guidelines on diagnosis and
treatment of brain metastases:
report of an EFNS Task Force
End-of-dose wearing off in
Parkinson disease: a 9-question
survey assessment
Evidence for systems-level
molecular mechanisms of
tumorigenesis
Health-related quality of life in
multiple system atrophy
Increase in body weight after
pramipexole treatment in
Parkinson's disease.
Individual-based model and
simulation of Plasmodium
falciparum infected erythrocyte in
vitro cultures
Interleukin 10, monocytes and
increased risk of early infection in
ischaemic stroke
LRRK2 mutations in Spanish
patients with Parkinson disease:
frequency, clinical features, and
incomplete penetrance
Management of paraneoplastic
neurological syndromes: report of
an EFNS Task Force
Modest MRI signal intensity
changes precede delayed cortical
necrosis after transient focal
ischemia in the rat
Neuro-oncology: setting new
standards of management
Neuropsychological deficits in
Parkinson's disease patients with
visual hallucinations
No association of the Val66Met
polymorphism of brain-derived
neurotrophic factor (BDNF) to
multiple sclerosis
Vargas M; Horcajada JP; Obach V; Revilla M;
Cervera A; Torres F; Planas AM; Mensa J;
Chamorro A
Stroke; a journal of cerebral
circulation; 2006 Feb; 37(2); p. 461-5
Blanco Y; Moral EA; Costa M; Gomez-Choco M;
Torres-Peraza JF; Alonso-Magdalena L; Alberch J;
Jaraquemada D; Arbizu T; Graus F; Saiz A
Neuroscience letters; 2006 Oct 9;
406(3); p. 270-5
Soffietti R; Cornu P; Delattre JY; Grant R; Graus F;
Grisold W; Heimans J; Hildebrand J; Hoskin P;
Kalljo M; Krauseneck P; Marosi C; Siegal T; Vecht C
Stacy M; Hauser R; Oertel W; Schapira A; Sethi K;
Stocchi F; Tolosa E
European journal of neurology; 2006
Jul; 13(7); p. 674-81
Hernandez P; Huerta-Cepas J; Montaner D; AlShahrour F; Valls J; Gomez L; Capella G; Dopazo J;
Pujana MA
Schrag A; Geser F; Stampfer-Kountchev M; Seppi
K; Sawires M; Kollensperger M; Scherfler C; Quinn
N; Pellecchia MT; Barone P; Del Sorbo F; Albanese
A; Ostergaard K; Dupont E; Cardozo A; Tolosa E;
Nilsson CF; Widner H; Lindvall O; Giladi N;
Gurevich T; Dan
Kumru H; Santamaria J; Valldeoriola F; Marti MJ;
Tolosa E
BMC genomics; 2007 Jun 20; 8; p.
185
Clinical neuropharmacology; 2006
Nov-Dec; 29(6); p. 312-21
Movement disorders; 2006 Jun; 21(6);
p. 809-15
Movement disorders 2006 Nov;
21(11); p. 1972-4
Ferrer J; Vidal J; Prats C; Valls J; Herreros E; Lopez Journal of theoretical biology; 2007
D; Giro A; Gargallo D
Oct 7; 248(3); p. 448-59
Chamorro A; Amaro S; Vargas M; Obach V; Cervera Journal of neurology, neurosurgery,
A; Torres F; Planas AM
and psychiatry; 2006 Nov; 77(11); p.
1279-81
Gaig C; Ezquerra M; Marti MJ; Munoz E;
Archives of neurology; 2006 Mar;
Valldeoriola F; Tolosa E
63(3); p. 377
Vedeler CA; Antoine JC; Giometto B; Graus F;
Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA;
Verschuuren JJ; Voltz R
Rojas S; Martin A; Justicia C; Falcon C; Bargallo N;
Chamorro A; Planas AM
European journal of neurology; 2006
Jul; 13(7); p. 682-90
Stroke; a journal of cerebral
circulation; 2006 Jun; 37(6); p. 152532
Graus F; Tortosa A
Lancet neurology; 2006 Jan; 5(1); p.
8-9
Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Movement disorders; 2006 Sep; 21(9);
Tolosa E
p. 1483-7
Blanco Y; Gomez-Choco M; Arostegui JL; Casanova Neuroscience letters; 2006 Apr 3;
B; Martinez-Rodriguez JE; Bosca I; Munteis E;
396(3); p. 217-9
Yague J; Graus F; Saiz A
37
No evidence of CRHR1 gene
involvement in progressive
supranuclear palsy
Progression of multiple system
atrophy (MSA): a prospective
natural history study by the
European MSA Study Group
(EMSA SG)
Protein kinase Cgamma
autoimmunity in paraneoplastic
cerebellar degeneration and nonsmall-cell lung cancer
Rapid eye movement sleep
behavior disorder and potassium
channel antibody-associated limbic
encephalitis
Rapid-eye-movement sleep
behaviour disorder as an early
marker for a neurodegenerative
disorder: a descriptive study
Response to 4-month treatment
with reboxetine in Parkinson's
disease patients with a major
depressive episode
Safety and tolerability of adjunctive
tolcapone treatment in patients with
early Parkinson's disease
The alpha-synuclein gene in
multiple system atrophy
Campdelacreu J; Gaig C; Ezquerra M; Munoz E;
Marti MJ; Valldeoriola F; Tolosa E
Neuroscience letters; 2006 Nov 27;
409(1); p. 61-4
Geser F; Wenning GK; Seppi K; StampferKountchev M; Scherfler C; Sawires M; Frick C;
Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P;
Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E;
Abele M; Klockgether T; Ostergaard K; Dupont E;
Schimke N; Eggert KM; Oe
Sabater L; Bataller L; Carpentier AF; Aguirre-Cruz
ML; Saiz A; Benyahia B; Dalmau J; Graus F
Movement disordersy; 2006 Feb;
21(2); p. 179-86
Journal of neurology, neurosurgery,
and psychiatry; 2006 Dec; 77(12); p.
1359-62
Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar Annals of neurology; 2006 Jan; 59(1);
C; Martinez-Rodriguez JE; Vincent A; Santamaria J p. 178-81
Iranzo A; Molinuevo JL; Santamaria J; Serradell M; Lancet neurology; 2006 Jul; 5(7); p.
Marti MJ; Valldeoriola F; Tolosa E
572-7
Pintor L; Bailles E; Valldeoriola F; Tolosa E; Marti
MJ; de Pablo J
General hospital psychiatry; 2006 JanFeb; 28(1); p. 59-64
Lees AJ; Ratziu V; Tolosa E; Oertel WH
Journal of neurology, neurosurgery,
and psychiatry; 2007 Sep; 78(9); p.
944-8
Ozawa T; Healy DG; Abou-Sleiman PM; Ahmadi KR; Journal of neurology, neurosurgery,
Quinn N; Lees AJ; Shaw K; Wullner U; Berciano J; and psychiatry; 2006 Apr; 77(4); p.
Moller JC; Kamm C; Burk K; Josephs KA; Barone P; 464-7
Tolosa E; Goldstein DB; Wenning G; Geser F;
Holton JL; Gasser T; Revesz T; Wood NW
Chamorro A; Hallenbeck J
Stroke; a journal of cerebral
circulation; 2006 Feb; 37(2); p. 291-3
The harms and benefits of
inflammatory and immune
responses in vascular disease
Uric acid reduces brain damage and Romanos E; Planas AM; Amaro S; Chamorro A
improves the benefits of rt-PA in a
rat model of thromboembolic stroke.
WAERS: an application for Webassisted estimation of relative
survival
Why does acute hyperglycemia
worsen the outcome of transient
focal cerebral ischemia? Role of
corticosteroids, inflammation, and
protein O-glycosylation
Revisió
Dystonia in Parkinson's disease
Journal of cerebral blood flow and
metabolism : official journal of the
International Society of Cerebral Blood
Flow and Metabolism; 2007 Jan;
27(1); p. 14-20
Cleries R; Valls J; Esteban L; Galvez J; Pareja L;
Medical informatics and the Internet in
Sanz X; Alliste L; Martinez JM; Moreno V; Bosch X; medicine; 2007 Sep; 32(3); p. 169-75
Borras JM; Ribes JM
Martin A; Rojas S; Chamorro A; Falcon C; Bargallo Stroke; a journal of cerebral
N; Planas AM;
circulation; 2006 May; 37(5); p. 128895
Tolosa E; Compta Y
Journal of neurology; 2006 Dec; 253
Suppl 7; p. VII7-13
Stroke; a journal of cerebral
circulation; 2006 Dec; 37(12); p. 30523
Immediate anticoagulation for acute Chamorro A
stroke in atrial fibrillation: yes
38
Residues from veterinary medicinal
products, growth promoters and
performance enhancers in foodproducing animals: a European
Union perspective
Review of the therapeutic
management of Parkinson's
disease. Report of a joint task force
of the European Federation of
Neurological Societies (EFNS) and
the Movement Disorder SocietyEuropean Section (MDS-ES). Part
II: late (complicated) Parkinson's
disease
Review of the therapeutic
management of Parkinson's
disease. Report of a joint task force
of the European Federation of
Neurological Societies and the
Movement Disorder SocietyEuropean Section. Part I: early
(uncomplicated) Parkinson's
disease.
Signalling pathways mediating
inflammatory responses in brain
ischaemia
The diagnosis of Parkinson's
disease
Thymus and myasthenia gravis:
antigen processing in the human
thymus and the consequences for
the generation of autoreactive T
cells
Cas clínic
de Andres C; Esquivel A; de Villoria
JG; Graus F; Sanchez-Ramon S
Serratosa J; Blass A; Rigau B; Mongrell B; Rigau T; Revue scientifique et technique
Tortades M; Tolosa E; Aguilar C; Ribo O; Balague J (International Office of Epizootics);
2006 Aug; 25(2); p. 637-53
Horstink M; Tolosa E; Bonuccelli U; Deuschl G;
European journal of neurology; 2006
Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel Nov; 13(11); p. 1186-202
W; Poewe W; Rascol O; Sampaio C
Horstink M; Tolosa E; Bonuccelli U; Deuschl G;
European journal of neurology; 2006
Friedman A; Kanovsky P; Larsen JP; Lees A; Oertel Nov; 13(11); p. 1170-85
W; Poewe W; Rascol O; Sampaio C
Planas AM; Gorina R; Chamorro A
Biochemical Society transactions;
2006 Dec; 34(Pt 6); p. 1267-70
Tolosa E; Wenning G; Poewe W
Lancet neurology; 2006 Jan; 5(1); p.
75-86
Melms A; Luther C; Stoeckle C; Poschel S; Schroth Acta neurologica Scandinavica
P; Varga M; Wienhold W; Tolosa E
Supplementum; 2006; 183; p. 12-3
de Andres C; Esquivel A; de Villoria JG; Graus F;
Sanchez-Ramon S
Journal of neurology, neurosurgery,
and psychiatry; 2006 Apr; 77(4); p.
562-3
MM1 variant of sporadic
Sanchez-Valle R; Santamaria J; Rey MJ; Rodriguez Neurologia (Barcelona, Spain); 2006
Creutzfeldt-Jakob disease with long A; Graus F; Saiz A
Oct; 21(8); p. 444-6
duration akinetic mutism state
NMO-IgG antibodies in
Zuliani L; Lopez de Munain A; Ruiz Martinez J;
Neurologia (Barcelona, Spain); 2006
neuromyelitis optica: a report of 2 Olascoaga J; Graus F; Saiz A
Jul-Aug; 21(6); p. 314-7
cases
Paraneoplastic encephalomyelitis Hernandez-Echebarria L; Saiz A; Ares A; Tejada J; Neurology; 2006 Feb 14; 66(3); p.
associated with pancreatic tumor
Garcia-Tunon L; Nieves C; Graus F
450-1
and anti-GAD antibodies
Pure autonomic failure with altered Compta Y; Marti MJ; Paredes P; Tolosa E
Archives of neurology; 2006 Apr;
dopamine transporter imaging
63(4); p. 604
Carta
Cognitive changes in Parkinson's Valldeoriola F; Tolosa E; Alegret M; Tolosa E; Rey Journal of neurology, neurosurgery,
disease during subthalamic
MJ; Morsi O; Pilleri M; Rumia J
and psychiatry; 2006 Apr; 77(4); p.
stimulation: a clinicopathologic
565-6
study
Hu-antibody-positive patients with Llado A; Carpentier AF; Honnorat J; Sillevis-Smitt Journal of neurology, neurosurgery,
or without cancer have similar
P; Twijnstra A; Blanco Y; Hart IK; Saiz A; Graus F and psychiatry; 2006 Aug; 77(8); p.
clinical profiles
996-7
39
Intronic c.573 + 79G>A
Obach V; Munoz X; Sala N; Garcia de Frutos P;
polymorphism of protein Z gene in Chamorro A
haemorrhagic and ischaemic stroke
Thrombosis and haemostasis; 2006
Jun; 95(6); p. 1040-1
Malalties Infeccioses
Malalties Infeccioses - Publicacions 2006
Titol
Autors
Original
A prospective survey of Human
Cervera C, Marcos MA, Linares L, Roig E, Benito N,
Herpesvirus-6 primary infection in Pumarola T, Moreno A
solid organ transplant recipients
A Review of Critical Periods for
R San Juan Garrido, JM Aguado, C Diaz-Pedroche,
Opportunistic Infection in the New O len, M Montejo, A Moreno, M Gurguí, J TorresTransplantation Era
Cisneros, F Pareja, J Segovia, M García, C
Lumbreras
An integral care telemedicine
Caceres C; Gomez EJ; Garcia F; Gatell JM; del
system for HIV/AIDS patients.
Pozo F
Antiretroviral activity of didanosine Blanco JL; Biglia A; De Lazzari E; Mallolas J;
in patients with different clusters of Martinez E; Pumarola T; Larrousse M; Milinkovic A;
reverse transcriptase mutations
Leon A; Lonca M; Laguno M; Gatell JM
Antiretroviral therapy of HIV
Gratacos L; Tuset M; Codina C; Miro JM; Mallolas
infection: duration and reasons for J; Miserachs N; Martin-Conde MT; del Cacho E;
changing the first therapeutic
Lazzari E; Ribas J; Gatell JM
regimen in 518 patients
Aorto-Cavitary Fistula in
Anguera I, Miro JM, Evangelista A, Cabell CH, San
Endocarditis Working Group.
Roman JA, Vilacosta I, Almirante B, Ripoll T,
Periannular complications in
Farinas MC, Anguita M, Navas E, Gonzalezinfective endocarditis involving
Juanatey C, Garcia-Bolao I, Munoz P, de Alarcon A,
native aortic valves
Sarria C, Rufi G, Miralles F, Pare C, Fowler VG Jr,
Mestres CA, de Lazzari E, Guma JR, Moreno A et
al.
Aorto-Cavitary Fistula in
Anguera I, Miro JM et al.
Endocarditis Working Group.
Periannular complications in
infective endocarditis involving
prosthetic aortic valves
Behcet's disease in an HIV-1Gomez-Puerta JA, Espinosa G, Miro JM, Sued O,
infected patient treated with highly Llibre JM, Cervera R, Font J
active antiretroviral therapy
Cardiac surgery in human
Mestres CA, Miro JM
immunodeficiency virus positive
patients
Changes over time in risk of initial Lampe FC; Gatell JM; Staszewski S; Johnson MA;
virological failure of combination
Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M;
antiretroviral therapy: a multicohort Fontas E; Krentz HB; Phillips AN
analysis, 1996 to 2002
Comparison of single and boosted Gatell JM, Miro JM, Zamora L
protease inhibitor versus
nonnucleoside reverse transcriptase
inhibitor-containing cART regimens
in antiretroviral-naive patients
starting cART after January 1, 2000
40
Cita
Transplantation. 2006;82:979-982
Transplantation 2006; 82: 1457-1462
International journal of medical
informatics; 2006 Sep; 75(9); p. 638-42
AIDS (London, England); 2006 Sep 11;
20(14); p. 1891-2
Medicina clinica; 2006 Feb 25; 126(7);
p. 241-5
Am J Cardiol. 2006 Nov 1;98(9):125460
Am J Cardiol. 2006 Nov 1;98(9):1261-8
Isr Med Assoc J. 2006 Jul;8(7):513-4
Ind J Thorac Cardiovasc Surg. 2006;
22:203-204
Archives of internal medicine; 2006 Mar
13; 166(5); p. 521
HIV Clin Trials. 2006 NovDec;7(6):271-84
Complications of Native and
Prosthetic Valve Infective
Endocarditis: Update in 2006
Complications of Native
andProsthetic Valve Infective
Endocarditis: Update in 2006
Cryopreserved mitral homograft in
the tricuspid position for infective
endocarditis: a valve that can be
repaired in the long-term (13 years)
Decreased pregnancy rate after invitro fertilization in HIV-infected
women receiving HAART.
Discontinuation of primary and
secondary Toxoplasma gondii
prophylaxis is safe in HIV-infected
patients after immunological
restoration with highly active
antiretroviral therapy: results of an
open, randomized, multicenter
clinical trial
Dynamics of T cells subsets and
lymphoproliferative responses
during structured treatment
interruption cycles and after
definitive interruption of HAART in
early chronic HIV type-1-infected
patients.
Effectiveness and safety of
abacavir, lamivudine, and
zidovudine in antiretroviral therapynaive HIV-infected patients: results
from a large multicenter
observational cohort
Effects of nandrolone decanoate
compared with placebo or
testosterone on HIV-associated
wasting
Factors associated with the
development of opportunistic
infections in HIV-1-infected adults
with high CD4+ cell counts: a
EuroSIDA study
Glutamate released by dendritic
cells as a novel modulator of T cell
activation
Group A streptococcal infections in
injection drug users in Barcelona,
Spain: epidemiologic, clinical, and
microbiologic analysis of 3 clusters
of cases from 2000 to 2003.
HIV treatment response and
prognosis in Europe and North
America in the first decade of highly
active antiretroviral therapy: a
collaborative analysis
Anguera I, Del Rio A, Moreno A, Pare C, Mestres
CA, Miro JM
Curr Infect Dis Rep. 2006 Jun;8(4):2808
Anguera I; Del Rio A; Moreno A; Pare C; Mestres
CA; Miro JM
Current infectious disease reports;
2006 Jun; 8(4); p. 280-8
Mestres CA, Castella M, Moreno A, Pare JC, del Rio J Heart Valve Dis. 2006 May;15(3):389A, Azqueta M, Fernandez C, Miro JM, Pomar JL
91
Coll O; Suy A; Figueras F; Vernaeve V; Martinez E; AIDS (London, England); 2006 Jan 2;
Mataro D; Durban M; Lonca M; Vidal R; Gatell JM 20(1); p. 121-3
Miro JM, Lopez JC, Podzamczer D, Pena JM,
Alberdi JC, Martinez E, Domingo P, Cosin J,
Claramonte X, Arribas JR, Santin M, Ribera E;
GESIDA 04/98 Study Group
Clin Infect Dis. 2006 Jul 1;43(1):79-89
Libois A; Lopez A; Garcia F; Castro P; Maleno MJ; AIDS research and human
Garcia A; Climent N; Arnedo M; Gallart T; Gatell
retroviruses;2006 Jul; 22(7); p. 657-66
JM; Plana M
Berenguer J; Perez-Elias MJ; Bellon JM; Knobel H; Journal of acquired immune deficiency
Rivas-Gonzalez P; Gatell JM; Miguelez M;
syndromes (1999); 2006 Feb 1; 41(2);
Hernandez-Quero J; Flores J; Soriano V; Santos I; p. 154-9
Podzamczer D; Sala M; Camba M; Resino S;
Gold J; Batterham MJ; Rekers H; Harms MK;
Geurts TB; Helmyr PM; Silva de Mendonca J;
Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti
F; Lee C; Horban A; Gatell J; Phanuphak P;
Prasithsirikul W; Gazzard B; Bloch M; Danner SA
Gatell JM, Miro JM, Zamora L
HIV medicine; 2006 Apr; 7(3); p. 14655
Pacheco R; Oliva H; Martinez-Navio JM; Climent N;
Ciruela F; Gatell JM; Gallart T; Mallol J; Lluis C;
Franco R
Sierra JM; Sanchez F; Castro P; Salvado M; de la
Red G; Libois A; Almela M; March F; Espanol M;
Sambeat MA; Romeu J; Brugal MT; Garcia de
Olalla P; Gatell JM; Vila J; Garcia F; Lopez
Colomes JL; Cayla JA; Coll P
Gatell JM, Miro JM, Zamora L
Journal of immunology (Baltimore, Md :
1950); 2006 Nov 15; 177(10); p. 6695704
Medicine; 2006 May; 85(3); p. 139-46
41
J Infect Dis. 2006 Sep 1;194(5):633-41
Lancet. 2006 Aug 5;368(9534):451-8
Increased risk of pre-eclampsia and
fetal death in HIV-infected pregnant
women receiving highly active
antiretroviral therapy.
Influence of Diabetes Mellitus on
the Clinical Manifestations and
Prognosis of Infective Endocarditis:
A report from the International
Collaboration on Endocarditis.
Merged Database
Influence of diabetes mellitus on the
clinical manifestations and
prognosis of infective endocarditis:
a report from the International
Collaboration on EndocarditisMerged Database
Intrathoracic fat in HIV-infected
patients.
Liver Transplantation in HIVInfected Patients: Update in 2006
Liver-related deaths in persons
infected with the human
immunodeficiency virus: the D:A:D
study
Management of end stage liver
disease (ESLD): what is the current
role of orthotopic liver
transplantation (OLT)?
Microbiologic features and outcome
of pneumonia in transplanted
patients
Mortality and morbidity in HIVinfected patients undergoing
coronary artery bypass surgery: a
case control study
Periannular Complications in
Infective Endocarditis Involving
Native Aortic Valves
Suy A; Martinez E; Coll O; Lonca M; Palacio M; de AIDS (London, England); 2006 Jan 2;
Lazzari E; Larrousse M; Milinkovic A; Hernandez S; 20(1); p. 59-66
Blanco JL; Mallolas J; Leon A; Vanrell JA; Gatell
JM
Kourany, W., Miró J., Moreno A., Corey R., Pappas Scand J Infect Dis. 2006; 38: 613-619
P., Abrutyn E., Hoen B., Habib G., Fowler V., Sexton
D., Olaison L., Cabell C
Kourany WM, Miro JM, Moreno A et al
Scand J Infect Dis. 2006;38(8):613-9
Blanco JL; Biglia A; Martinez E; Sanchez M; de
HIV medicine; 2006 May; 7(4); p. 213-7
Lazzari E; Leon A; Milinkovic A; Larrousse M;
Lonca M; Laguno M; Mallolas J; Gatell JM
Miró JM, Murillas J, Laguno M, Tuset M, Agüero F, Hepatology Rev. 2006;3:16-29
Moreno A, Rimola A and the Hospital Clinic OLT in
HIV Working Group
Gatell JM, Miro JM, Zamora L
Arch Intern Med. 2006 Aug 1428;166(15):1632-41
Miro JM, Laguno M, Moreno A, Rimola A and the
Hospital Clinic OLT in HIV Working Group
C Cervera, C Agustí, MA Marcos, T Pumarola, F
Cofán, M Navasa, F Perez-Villa, Antonio Torres,
AMoreno
Jimenez-Exposito MJ, Mestres CA, Claramonte X,
Cartana R, Josa M, Pomar JL, Mulet J, Miro JM; en
representacion del Grupo de Estudio de
Endocarditis del Hospital Clinic-IDIBAPS
Anguera I., Miro JM., Evangelista A., Cabell C., San
Roman JA., Vilacosta I., Almirante B., Ripoll T.,
Fariñas MC., Anguita M., Navas E., GonzalezJuanatey C., Garcia-Bolao I., Muñoz P., de Alarcón
A., Sarriá C., Rufi G., Miralles F., Pare C., Fowler V.,
Mestres CA., de Lazzari E., Guma JR., Moreno A.,
Corey GR and the Aorto-Cavitary Fistula in
Endocarditis Working Group
Primary human immunodeficiency Sued O; Miro JM; Alquezar A; Claramonte X;
virus type 1 infection: clinical,
Garcia F; Plana M; Arnedo M; de Lazzari E; Gil C;
virological and immunological
Manzardo C; Blanco JL; Martinez E; Mallolas J;
characteristics of 75 patients (1997- Joseph J; Pumarola T; Gallart T; Gatell JM
2003).
Progress towards an HIV vaccine Joseph J; Saubi N; Pezzat E; Gatell JM;
based on recombinant bacillus
Calmette-Guerin: failures and
challenges.
42
J Hepatol. 2006;44(1 Suppl):S140-5
Diag Microbiol Infect Dis.
2006;55(1):47-54
Rev Esp Cardiol. 2006 Mar;59(3):276-9
Am J Cardiol 2006; 98: 1254-1260
Enfermedades infecciosas y
microbiologia clinica; 2006 Apr; 24(4);
p. 238-44
Expert review of vaccines; 2006 Dec;
5(6); p. 827-38
Rates of disease progression
according to initial highly active
antiretroviral therapy regimen: a
collaborative analysis of 12
prospective cohort studies
Regional changes over time in initial
virologic response rates to
combination antiretroviral therapy
across Europe
Regional changes over time in initial
virologic response rates to
combination antiretroviral therapy
across Europe.
Relationship between antiretrovirals
used as part of a cART regimen and
CD4 cell count increases in patients
with suppressed viremia
Reporting and evaluation of HIVrelated clinical endpoints in two
multicenter international clinical
trials
Sensitivity and specificity of nested
and real-time PCR for the detection
of Pneumocystis jiroveci in clinical
specimens
Gatell JM, Miro JM, Zamora L
J Infect Dis. 2006 Sep 1;194(5):612-22
Gatell JM, Miro JM, Zamora L
J Acquir Immune Defic Syndr. 2006
Jun;42(2):229-37
Bannister WP; Kirk O; Gatell JM; Knysz B; Viard
JP; Mens H; Monforte AD; Phillips AN; Mocroft A;
Lundgren JD
Journal of acquired immune deficiency
syndromes (1999); 2006 Jun; 42(2); p.
229-37
Gatell JM, Miro JM, Zamora L
AIDS 2006 May 12;20(8):1141-50
Lifson AR; Rhame FS; Belloso WH; Dragsted UB;
El-Sadr WM; Gatell JM; Hoy JF; Krum EA; Nelson
R; Pedersen C; Pett SL; Davey RT Jr;
HIV clinical trials; 2006 May-Jun; 7(3);
p. 125-41
Alvarez-Martinez MJ; Miro JM; Valls ME; Moreno A;
Rivas PV; Sole M; Benito N; Domingo P; Munoz C;
Rivera E; Zar HJ; Wissmann G; Diehl AR; Prolla JC;
de Anta MT; Gatell JM; Wilson PE; Meshnick SR
and the Spanish PCP Working Group
Tacrolimus treatment of
Naranjo-Gomez M; Climent N; Cos J; Oliva H; Bofill
plasmacytoid dendritic cells inhibits M; Gatell JM; Gallart T; Pujol-Borrell R; Borras FE
dinucleotide (CpG-)-induced tumour
necrosis factor-alpha secretion.
The cryopreserved mitral homograft Carlos-A Mestres, Manuel Castellá, Asunción
in the tricuspid position for infective Moreno, J.Carlos Paré, Ana del Rio, Manuel
endocarditis
Azqueta, Claudio Fernández, José Mª Miró, José
Luis Pomar and the Hospital Clínic Endocarditis
Study Group
The feasibility of clinical endpoint
Gatell JM, Miro JM, Zamora L
trials in HIV infection in the highly
active antiretroviral treatment
(HAART) era
The International Collaboration on Lalani T, Kanafani ZA, Chu VH, Moore L, Corey GR,
Endocarditis Merged Database
Pappas P, Woods CW, Cabell CH, Hoen B, SeltonStudy Group. Prosthetic valve
Suty C, Doco-Lecompte T, Chirouze C, Raoult D,
endocarditis due to coagulaseMiro JM et al.
negative staphylococci: findings
from the International Collaboration
on Endocarditis Merged Database
The use of the Framingham
Gatell JM, Miro JM, Zamora L
equation to predict myocardial
infarctions in HIV-infected patients:
comparison with observed events in
the D:A:D Study
Transmission of HIV-1 from an
Mallolas J; Arnedo M; Pumarola T; Erice A; Blanco
obstetrician to a patient during a
JL; Martinez E; Gatell JM
caesarean section
43
Diagnostic microbiology and infectious
disease; 2006 Oct; 56(2); p. 153-60
Immunology; 2006 Dec; 119(4); p. 48898
J Heart Valve Dis.. 2006
May;15(3):389-91
Clin Trials. 2006;3(2):119-32
Eur J Clin Microbiol Infect Dis. 2006
Jun;25(6):365-8
HIV Med. 2006 May;7(4):218-30
AIDS (London, England); 2006 Jan 9;
20(2); p. 285-7
Treatment for adult HIV infection:
2006 recommendations of the
International AIDS Society--USA
panel
Treatment for adult HIV infection:
2006 recommendations of the
International AIDS Society-USA
panel.
Revisió
¿Podemos mejorar el pronóstico de
la endocarditis estafilocócica?
Complications of Native and
Prosthetic Valve Infective
Endocarditis: Update in 2006
Enfermedades Infecciosas y
Microbiología Clínica: actividad
editorial 2002-2005
Infections due to HIV-2 and HTLV1/2 in Spain
Hammer SM; Saag MS; Schechter M; Montaner JS;
Schooley RT; Jacobsen DM; Thompson MA;
Carpenter CC; Fischl MA; Gazzard BG; Gatell JM;
Hirsch MS; Katzenstein DA; Richman DD; Vella S;
Yeni PG; Volberding PA
Hammer SM; Saag MS; Schechter M; Montaner JS;
Schooley RT; Jacobsen DM; Thompson MA;
Carpenter CC; Fischl MA; Gazzard BG; Gatell JM;
Hirsch MS; Katzenstein DA; Richman DD; Vella S;
Yeni PG; Volberding PA
Topics in HIV medicine : a publication
of the International AIDS Society, USA;
2006 Aug-Sep; 14(3); p. 827-43
del Río A, Miró JM
Anguera I, Del Rio A, Moreno A, Pare C, Mestres
CA, Miro JM
Enferm Infecc Microbiol Clin. 2006;
5(3):58-70
Curr Infect Dis Rep. 2006 Jun;8(4):2808
Almirante B, Alonso J, Martinez-Martinez L, Miro
JM, Pascual A
Enferm Infecc Microbiol Clin. 2006;
24(3):143-146
Toro C, Soriano V; Grupo Espanol de Estudio del
VIH-2 y HTLV-1/2 (Miro JM, Sued O, Hosp. Clinic.
Barcelona, Spain)
Interacciones de los fármacos
Tuset M, Miro JM, Carcelero E, Sarasa M, Codina C,
antirretrovirales: actualización
Ribas J
Management of end stage liver
JM Miró, M Laguno, A Moreno, A Rimola, the
disease (ESLD): What is the current Hospital Clínic OLT in VIH Working Group
role of orthotopic liver
tranbsplantation (OLT)?
Miro JM,
Recommendations from the
GESIDA/Spanish AIDS Plan
regarding antiretroviral treatment in
adults with human
immunodeficiency virus infection
(Update January 2007)
Carta
Antiretroviral therapy in patients
Sued O, Iribarren JA, Arrizabalaga J, Miro JM
with primary HIV infection
Antiretroviral treatment in patient
Arribas JR, Pulido F, Gonzalez-Garcia JJ, Miro JM
with advanced immunosuppression
Considerations about the value of Martinez E; Milinkovic A; Bianchi L; Gatell JM
sonography for the measurement of
regional body fat.
Noninvasive diagnosis of
Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante
mitochondrial dysfunction in
AB; Lopez S; Cardellach F; Gatell JM; Casademont
HAART-related hyperlactatemia
J
Transmission of HIV-1 from an
obstetrician to a patient during a
caesarean section
Llibre
Guía de bolsillo de interacciones
farmacológicas en VIH
Resumen Científico ICAAC-2006
Mallolas J; Gatell JM; Bruguera M
Tuset M, Miró JM, Codina C, Ribas J
Arribas JR, Miró JM, Rodríguez JL, De la Torre J
(Eds)
Capítol llibre
44
JAMA : the journal of the American
Medical Association; 2006 Aug 16;
296(7); p. 827
Enferm Infecc Microbiol Clin. 2006
Oct;24(8):481-2
Infecciones e Inmunología. 2006; 5 (2):
18-43
Journal of Hepatology. 2006; 44; S1405
Enferm Infecc Microbiol Clin. 2007
Jan;25(1):32-53
Med Clin (Barc). 2006 Feb
4;126(4):157
Med Clin (Barc). 2006 Feb
4;126(4):157-8
AIDS (London, England); 2006 Feb 14;
20(3); p. 465-6
Clinical infectious diseases : an official
publication of the Infectious Diseases
Society of America; 2006 Feb 15;
42(4); p. 584-5
AIDS (London, England); 2006 Aug 22;
20(13); p. 1785
Sexta edición. Madrid. SiCom XXI SL.
2006 Depósito legal: M-38896-2006
Octaba Edición. Barcelona. Ediciones
Permanyer. 2006. ISBN: 84-935225-46
Endocarditis infecciosa sobre
válvula nativa.
Farmacocinética e interacciones de
tripanavir
Infección aguda por el VIH,
tratamiento antirretroviral (TARV)
inicial, paradas del TARV, terapias
inmunomediadas y profilaxis
postexposición accidental
Infección aguda por el VIH,
tratamiento antirretroviral (TARV)
inicial, paradas del TARV, terapias
inmunomediadas y profilaxis
postexposición accidental (PEP)
Infecciones producidas por el grupo
Herpes (no VIH, no trasplante) y
otros virus
Liver transplantation in HIV-infected
patients
Profilaxis y tratamiento de las
infecciones oportunistas en los
pacientes con Sid
Tratamiento de la infección por el
virus de la inmunodeficiencia
humana
Truvada un fármaco esencial en el
tratamiento inicial. Capítulo 3
Miró JM, Tornos P, Fernández-Guerrero ML
En: Tratado SEIMC de Patología
Infecciosa. Ausina V, Moreno S (Ed.).
Segunda edición: Capítulo 132.
Buenos Aires-Madrid: Editorial Médica
Panamericana SA. 2006: 1293-1313
Tuset M, Gratacòs L, Codina C, Miró JM
Gatell JM, Mensa J y Zamora L (Eds).
Tripinavir el Inhibidor de la proteasa de
una generación. Capítulo 6. Barcelona.
Editorial Antares, SCP . 2006: 107-143
Miró JM
Arribas JR, Miró JM, Rodríguez JL, De
la Torre Cisneros J (Eds).Resumen
Científico ICAAC 2005. 7ª Edición.
Barcelona. Ediciones P. Permanyer.
2006:55-62
Miró JM
Arribas JR, Miró JM, Rodríguez JL, De
la Torre Cisneros J (Eds).Resumen
Científico ICAAC 2006. 8ª Edición.
Barcelona. Ediciones Permanyer.
2006:67-75
Fortún J, Moreno A
En: Resumen Científico ICAAC-2006.
Barcelona, Ediciones Permanyer SL.
2006:107-13
Miró JM, Agüero F, Murillas J, Laguno M, Tuset M, Mallolas J (Ed). HCV-HIV coinfection.
Moreno A, Rimola A
Chapter 5. Barcelona. Editorial P.
Permanyer. 2006: 109-126
Sued O, García F, Miró JM
García JE, Gobernado M, Picazo JJ,
Prieto J (Eds). Antimicrobianos en
Medicina. 2ª Edición. Capítulo 50.
Barcelona. Editorial Prous Science, SA.
2006: 641-654
Mallolas J, Miró JM, Gatell J
García JE, Gobernado M, Picazo JJ,
Prieto J (Eds). Antimicrobianos en
Medicina. 2ª Edición. Capítulo 49.
Barcelona. Editorial Prous Science, SA.
2006: 633-640
Diego E, Fontanals S, Tuset M, Martín M, Miró JM Farmacocinética e interacciones
farmacocinéticas de Truvada ®. Gatell
JM, Mensa J y Zamora L (Eds).
Barcelona. Editorial Antares, SCP.
2006: 33-68
Malalties Infeccioses - Projectes de recerca finançats 2006
Investigador
Principal
Referència Ajut
Entitat
Nom Projecte
Import
Durada
Gatel JM
?
Fundación Mútua
Madrileña
Construcción de una vacuna contra el virus de la
65.000
inmunodeficiencia humana tipo 1 basada en BCG y virus
vaccinia
2005-2008
Gatell JM
SAFR2005-05566
?
Estudio de la respuesta inmunitaria in vitro a una vacuna 80.000,00
terapñeutica contra el VIH-1 reparada con células
dendríticas mieloides autólogas pulsadas con diferentes
inmunogenos
2005-2008
Gatell JM
?
Concerted Action
Eurosida
European Union. Program
Biomed 2
Gatell JM
safr2005-05566
?
Estudio de la respuesta inmunitaria in vitro a una vacuna 80.000
terapéutica contra el VIH-1 reparada con células
dendríticas micloides autólogas pulsadas con diferentes
inmunógenos.
2005-2008
Gatell JM
?
Fundación Mútua
Construcción de unaq vacuna contra el virus de la
2005-2008
?
45
65.000
2004-2006
Madrileña
inmunodeficiencia humana tipo I basada en BCG y virus
vaccinia.
Gatell JM
?
Proyecto Orvacs
Vacunas terapéuticas contra el VIH
?
2004-2006
Gatell JM
FIS 050130
Ministerio Sanidad y
Consumo
Proyectos coordinados en epidemiología, investigación
básica y clínica de la red de investigación en SIDA (Ris)
para el año 2006.
53.550
2006
Miro JM
PI 040363 FIS
Fondo Investigacion
Sanitaria
Estudio piloto del tratamiento inmunomediado de la
148.925
infección aguda por el VIH con el fin de inducir una fuerte
respuesta inmunoespecífica frente al VIH que permita el
control de la replicación viral sin tratamiento retroviral
(TARV)
2005-2007
Miro JM
TOH/VIH-05
FIPSE
Estudio FIPSE de trasplante hepático en pacientes
infectados por el VIH en España. Estudio Gesida 45-05
571.359,8
2005-2008
Moreno MA
?
Mútua Automovilística
Madrileña
Investigación en el trasplante
60.000
2004-2006
Moreno MA
FIS PI050315
Fondo Investigacion
Sanitaria
Infección y trasplante. Consolidación de RESITRA en el
marco RETICS. Explotación de la cohorte RESITRA
20.349
2006
Malalties Reumatològiques i del Sistema Immune
Malalties Reumatològiques i del Sistema Immune - Publicacions 2006
Títol
Autors
Original
Allelic diversity and affinity variants Muñoz-Saa I, Cambra A, Pallares L, Espinosa G,
of MICA are imbalanced in Spanish Juan A, Pujalte F, Matamoros N, Mila J, Julia MR
patients with Behcet's disease
Anti-inflammatory and
Ostensen M; Khamashta M; Lockshin M; Parke A;
immunosuppressive drugs and
Brucato A; Carp H; Doria A; Rai R; Meroni P; Cetin
reproduction
I; Derksen R; Branch W; Motta M; Gordon C; RuizIrastorza G; Spinillo A; Friedman D; Cimaz R;
Czeizel A; Piette JC; Cervera R; Levy RA; Clementi
M; De Caroli
Antiphospholipid antibodies
Gómez-Puerta JA, Cervera R, Espinosa G, Aguiló
associated with malignancies:
S, Bucciarelli S, Ramos-Casals M, Ingelmo M,
Clinical and pathological
Asherson RA, Font J
characteristics of 120 patients
Atypical autoantibodies in patients Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S;
with primary Sjogren syndrome:
Gil V; Delgado G; Bove A; Font J
clinical characteristics and follow-up
of 82 cases
Autoantibodies and prediction of
Shoenfeld Y; Carp HJ; Molina V; Blank M; Cervera
reproductive failure
R; Balasch J; Tincani A; Faden D; Lojacono A;
Doria A; Konova E; Meroni PL
Biochemical response to
Peris P, Alvarez L, Vidal S, Kasper D, Leeming DJ,
bisphosphonate therapy in pagetic Monegal A, Angeles Martinez M, Pons F,
patients with skull involvement
Guanabens N
Camurati-Engelmann disease:
Janssens K, Vanhoenacker F, Bonduelle M,
review of the clinical, radiological,
Verbruggen L, Van Maldergem L, Ralston S,
and molecular data of 24 families
Guanabens N, Migone N, Wientroub S, Divizia MT,
and implications for diagnosis and Bergmann C, Bennett C, Simsek S, Melancon S,
treatment
Cundy T, Van Hul W
Catastrophic antiphospholipid
Gomez-Puerta JA; Salgado E; Cervera R; Aguilo S;
syndrome presenting with renal
Ramos-Casals M; Soler M; Torras A; Font J
thrombotic microangiopathy and
diffuse proliferative
glomerulonephritis
46
Cita
Scand J Immunol 2006; 64: 77-82
Arthritis research & therapy; 2006;
8(3); p. 209
Semin Arthritis Rheum 2006; 35: 32232
Seminars in arthritis and rheumatism;
2006 Apr; 35(5); p. 312-21
American journal of reproductive
immunology (New York, N.Y : 1989);
2006 Nov-Dec; 56(5-6); p. 337-44
Calcif Tissue Int. 2006 Jul;79(1):22-6
J Med Genet. 2006 Jan;43(1):1-11
Clinical and experimental
rheumatology; 2006 Jan-Feb; 24(1); p.
110
Characterization and differentiation
of autoimmune versus viral liver
involvement in patients with
Sjogren's syndrome
Circulating auto-antibodies against
nuclear and non-nuclear antigens in
primary Sjogren's syndrome:
prevalence and clinical significance
in 335 patients
Epidemiology of systemic lupus
erythematosus at the change of the
millennium: lessons from the EuroLupus and the LUMINA projects
European attempts to set guidelines
for improving diagnostics of
autoimmune rheumatic disorders
Impaired factor XIIa-dependent
activation of fibrinolysis in treated
antiphospholipid syndrome
gestations developing latepregnancy complications
Infections in systemic lupus
erythematosus: a prospective and
controlled study of 110 patients
Inhaled steroids do not decrease
bone mineral density but increase
risk of fractures: data from the
GIUMO Study Group
International consensus statement
on an update of the classification
criteria for definite antiphospholipid
syndrome (APS)
Life-threatening cryoglobulinemia:
clinical and immunological
characterization of 29 cases
Mortality in the catastrophic
antiphospholipid syndrome: causes
of death and prognostic factors in a
series of 250 patients
nhaled steroids do not decrease
bone mineral density but increase
risk of fractures: data from the
GIUMO Study Group
Resultados del tratamiento con
pilocarpina oral en 100 pacientes
con síndrome de Sjögren primario
The acute respiratory distress
syndrome in catastrophic
antiphospholipid syndrome: analysis
of a series of 47 patients
Vasculitis in systemic lupus
erythematosus: prevalence and
clinical characteristics in 670
patients
Revisió
Anti-chromatin (anti-nucleosome)
antibodies
Ramos-Casals M, Sanchez-Tapias JM, Pares A,
Forns X, Brito-Zeron P, Nardi N, Vazquez P, Velez
D, Arias I, Bove A, Plaza J, Rodes J, Font J
J Rheumatol 2006; 33: 1593-9
Nardi N; Brito-Zeron P; Ramos-Casals M; Aguilo S; Clinical rheumatology; 2006 May;
Cervera R; Ingelmo M; Font J
25(3); p. 341-6
Cervera R; Khamashta MA
Lupus; 2006; 15(1); p. 1-2
Wiik A; Cervera R; Haass M; Kallenberg C;
Lupus; 2006; 15(7); p. 391-6
Khamashta M; Meroni PL; Piette JC; Schmitt R;
Shoenfeld Y
Carmona F; Lazaro I; Reverter JC; Tassies D; Font American journal of obstetrics and
J; Cervera R; Balasch J
gynecology; 2006 Feb; 194(2); p. 45765
Bosch X; Guilabert A; Pallares L; Cerveral R;
Ramos-Casals M; Bove A; Ingelmo M; Font J
Lupus; 2006; 15(9); p. 584-9
Sosa M, Saavedra P, Valero C, Guanabens N,
Nogues X, del Pino-Montes J, Mosquera J, Alegre
J, Gomez-Alonso C, Munoz-Torres M, Quesada M,
Perez-Cano R,GIUMO Study Group
Miyakis S; Lockshin MD; Atsumi T; Branch DW;
Brey RL; Cervera R; Derksen RH; DE Groot PG;
Koike T; Meroni PL; Reber G; Shoenfeld Y; Tincani
A; Vlachoyiannopoulos PG; Krilis SA
Ramos-Casals M, Robles A, Brito-Zeron P, Nardi N,
Nicolas JM, Forns X, Plaza J, Yague J, SanchezTapias JM, Font J
Bucciarelli S; Espinosa G; Cervera R; Erkan D;
Gomez-Puerta JA; Ramos-Casals M; Font J;
Asherson RA
Journal of Clinical Densitometry
2006;9:154-8
Jodar E, Torrijos A, Lozano-Tonkin C, Diaz-Curiel
M, GIUMO Study Group
J Clin Densitom. 2006 AprJun;9(2):154-8
Brito-Zerón P, Ramos-Casals M, Nardi N, Font J
Med Clin (Barc) 2006; 126: 637
Bucciarelli S; Espinosa G; Asherson RA; Cervera
R; Claver G; Gomez-Puerta JA; Ramos-Casals M;
Ingelmo M
Annals of the rheumatic diseases;
2006 Jan; 65(1); p. 81-6
Journal of thrombosis and
haemostasis : JTH; 2006 Feb; 4(2); p.
295-306
Semin Arthritis Rheum 2006; 36: 18996.
Arthritis and rheumatism; 2006 Aug;
54(8); p. 2568-76
Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron Medicine; 2006 Mar; 85(2); p. 95-104
P; Bove A; Delgado G; Cervera R; Ingelmo M; Font
J
Gomez-Puerta JA; Burlingame RW; Cervera R
47
Lupus; 2006; 15(7); p. 408-11
Antineutrophil cytoplasmic
antibodies
Antiphospholipid antibodies
associated with malignancies:
clinical and pathological
characteristics of 120 patients
Catastrophic antiphospholipid
syndrome
Catastrophic antiphospholipid
syndrome
European Working Party on
Systemic Lupus Erythematosus: a
15-year report
Insulin resistance, chronic
inflammatory state and the link with
systemic lupus erythematosusrelated coronary disease
Laboratory studies on
pathophysiology of the catastrophic
antiphospholipid syndrome
Lessons from the catastrophic
antiphospholipid syndrome (CAPS)
registry
Mortality in the catastrophic
antiphospholipid syndrome: causes
of death and prognostic factors
Pathophysiology of Sjogren's
syndrome
Pregnancy and puerperium are high
susceptibility periods for the
development of catastrophic
antiphospholipid syndrome
Systemic lupus erythematosus in
Europe at the change of the
millennium: lessons from the "EuroLupus Project"
The catastrophic antiphospholipid
(Asherson's) syndrome and
malignancies
Treatment of bone disorders in liver
disease
Cas Clínic
Behcet's disease in an HIV-1infected patient treated with highly
active antiretroviral therapy
Bilateral tibial stress fracture
presenting as painful edemas in
lower limbs
Fixed ceramometallic prostheses
over anterior and transzygomatic
implants by using the sinus slot
technique--report of a case
Bosch X; Guilabert A; Font J
Lancet; 2006 Jul 29; 368(9533); p. 404
Gomez-Puerta JA; Cervera R; Espinosa G; Aguilo
S; Bucciarelli S; Ramos-Casals M; Ingelmo M;
Asherson RA; Font J
Seminars in arthritis and rheumatism;
2006 Apr; 35(5); p. 322-3295-104
Cervera R; Asherton RA
Pathophysiology of haemostasis and
thrombosis; 2006; 35(1-2); p. 181-6
Rheumatic diseases clinics of North
America; 2006 Aug; 32(3); p. 575-90
Autoimmunity reviews; 2006 Oct; 5(8);
p. 549-53
Cervera R; Asherson RA; Font J
Cervera R; Font J; Shoenfeld Y
Escarcega RO; Garcia-Carrasco M; FuentesAutoimmunity reviews; 2006 Nov; 6(1);
Alexandro S; Jara LJ; Rojas-Rodriguez J; Escobar- p. 48-53
Linares LE; Cervera R
Espinosa G; Bucciarelli S; Cervera R; GomezPuerta JA; Font J
Autoimmunity reviews; 2006 Dec; 6(2);
p. 68-71
Cervera R; Espinosa G; Bucciarelli S; GomezPuerta JA; Font J
Autoimmunity reviews; 2006 Dec; 6(2);
p. 81-4
Bucciarelli S; Cervera R; Espinosa G; GomezPuerta JA; Ramos-Casals M; Font J
Autoimmunity reviews; 2006 Dec; 6(2);
p. 72-5
Garcia-Carrasco M; Fuentes-Alexandro S;
Escarcega RO; Salgado G; Riebeling C; Cervera R
Gomez-Puerta JA; Cervera R; Espinosa G;
Bucciarelli S; Font J
Archives of medical research; 2006
Nov; 37(8); p. 921-32
Autoimmunity reviews; 2006 Dec; 6(2);
p. 85-8
Cervera R; Abarca-Costalago M; Abramovicz D;
Allegri F; Annunziata P; Aydintug AO; Bacarelli
MR; Bellisai F; Bernardino I; Biernat-Kaluza E;
Blockmans D; Boki K; Bracci L; Campanella V;
Camps MT; Carcassi C; Cattaneo R; Cauli A;
Cervera R; Chwalinska-Sad
Miesbach W; Asherson RA; Cervera R; Shoenfeld
Y; Puerta JG; Bucciarelli S; Espinoza G; Font J
Autoimmunity reviews; 2006 Mar; 5(3);
p. 180-6
Pares A, Guanabens N
J Hepatol. 2006 Sep;45(3):445-53
Gomez-Puerta JA; Espinosa G; Miro JM; Sued O;
Llibre JM; Cervera R; Font J
IMAJ; 2006 Jul; 8(7); p. 513-4
Peris P, Monegal A, Martinez M, Guanabens N
Joint Bone Spine. 2006;73:557-9
utoimmunity reviews; 2006 Dec; 6(2);
p. 94-7
Penarrocha-Diago M; Boronat A; Cervera R; Garcia The Journal of oral implantology; 2006;
B
32(1); p. 38-40
48
Multifocal avascular necrosis after
liver transplantation: an unusual
presentation of the antiphospholipid
syndrome
Multifocal avascular necrosis after
liver transplantation: an unusual
presentation of the antiphospholipid
syndrome
Editorial
Infectious origin of the
antiphospholipid syndrome
Nonthrombotic manifestations of the
antiphospholipid syndrome: away
from thrombosis?
Primary pulmonary arterial
hypertension and the systemic
autoimmune diseases
Carta
Antiphospholipid antibodyassociated thrombocytopenia and
the paradoxical risk of thrombosis
Antiphospholipid syndrome and
minimal change nephropathy
V meeting of the European forum on
antiphospholipid antibodies
Capítol Llibre
Marcadores bioquímicos del
recambio óseo en la evaluación de
la enfermedad
Mundo J; Peris P; Monegal A; Navasa M; Cervera
R; Guaniabens N
Lupus; 2006; 15(5); p. 304-7
Mundo J, Peris P, Monegal A, Navasa M, Cervera R,
Guañabens N
Lupus 2006;15:304:7
Shoenfeld Y; Blank M; Cervera R; Font J; Raschi E;
Meroni PL
Asherson RA; Cervera R; Shepshelovich D;
Shoenfeld Y
Annals of the rheumatic diseases;
2006 Jan; 65(1); p. 2-6
The Journal of rheumatology; 2006
Jun; 33(6); p. 1038-44
Cervera R; Asherson RA
IMAJ; 2006 Apr; 8(4); p. 277-9
Fortea J; Obach V; Cervera R; Gamarra AI
Lupus; 2006; 15(1); p. 58
Rossinol T; Cervera R; Lopez C; Sole M; RamosCasals M; Font J
Cervera R; Font J; Tincani A; Boffa MC
Lupus; 2006; 15(8); p. 547-8
Peris P, Alvarez L, Guañabens N
En “Enfermedad Ósea de Paget. SCM
eds, 2006; pp:71-80
Autoimmunity reviews; 2006 Aug; 5(7);
p. 499-507
Malalties Reumatològiques i del Sistema Immune - Projectes de recerca finançats 2006
Inv. Principal
Ref. Ajut
Entitat
Cervera R
PI 03/028
Guañabens N
PI050044
Nom Projecte
Import €
Durada
Ministerio Alteraciones genéticas en el funcionalismo plaquetario, la fibrinolisis y
y Consumo ma inmunitario innato como factores predisponentes de arteriosclerosis
en pacientes con lupus eritematoso sistémico
116.265
2003-2006
FIS
??
2006-2008
Estudio del efecto bifásico de la hormona paratiroidea (PTH) sobre
stos humanos primarios en cultivo. Acción sobre el sistema OPG/RANKL
rcadores de diferenciación osteoblástica RUNX2/CBFA1, osteocalcina y
geno tipo I
Medicina d'Atenció Primària
Malalties d'Atenció Primària - Publicacions 2006
Títol
Autors
Cita
Original
Análisis de los estudios publicados Márquez E, Vil V, Casado JJ, Martell N, de la Figuera Aten Primaria 2006; 38:325-32
sobre el incumplimiento terapéutico M, et al.
en la hipertensión arterial en
España entre los años 1984 y 2005
49
Automedida de la presión arterial
domiciliaria. Influencia del sistema
de cáculo de la media en el
diagnóstico de la Hipertensión de
bata blanca
Bacterial etiology of chronic
bronchitis exacerbations treated by
primary care physicians
Consumo de fruta y verduras en la
prevención del ictus. ¿Incide el
consumo de frutas y verduras en el
riesgo de presentar un ictus?
Effect of intervention promoting a
reduction in antibiotic prescribing by
improvement of a diagnostic
procedures: a prospective, before
and after study in general practice
Effect of intervention promoting a
reduction in antibiotic prescribing by
improvement of diagnostic
procedures: a prospective, before
and after study in general practice.
Effects of valsartan compared to
amlodipine on preventing type 2
diabetes in high-risk hypertensive
patients: the VALUE trial
Efficacy of a home blood pressure
monitoring programme on
therapeutic compliance in
hypertension: the EAPACUM-HTA
study
Estimated risk of a first stroke and
conditioning factors in Spanish
hypertensive women. The RIMH
study.
Estrategias para un control eficaz
dela hipertensión arterial en
España. Documento de consenso
Etiología bacteriana de la
agudización de la bronquitis crónica
en atención primaria
Factores de riesgo de elevado
coste de las agudizaciones de la
bronquitis crónica y la EPOC
Home blood presure self-monitoing:
diagnostic performance in whitecoat hypertension
Indicadores de calidad en unidades
asistenciales de hipertensión
arterial en España: indicadores de
estructura en el estudio QUALITHA
Predictors of adverse outcome
among patients with hypertension
and coronary artery disease
J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX Aten Primaria 2006;38:212-8
Naberan, A. Botey
Llor C; Cots JM; Herreras A
Archivos de bronconeumologia; 2006
Aug; 42(8); p. 388-93
Coca A.
Jano 2006; 1629:39-40
Bjerrum L, Cots JM, Llor C, Molist N, Munck A
Euro J Clin Pharmacol 2006; 62: 9138
Bjerrum L; Cots JM; Llor C; Molist N; Munck A
European journal of clinical
pharmacology; 2006 Nov; 62(11); p.
913-8
Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Journal of Hypertension 2006; 24: 1405Weber MA, Coca A, Ekman S, Gired X, Jamerson K, 1412
Larochelle P, MacDonald ThM, Schmieder RE, Schork
MA, Stolf P, Viskoper R, Widimsky J, Zanchetti A, for
the VALUE Trial Investigators
Marquez-Contreras E, Martell-Claros N, Gil-Guillen J Hypertens. 2006 Jan;24(1):169-75
V, de la Figuera-Von Wichmann M, Casado-Martinez
JJ, Martin-de Pablos JL, et al.
Coca A; Redon J; Cea-Calvo L; Lozano JV; Navarro Blood pressure; 2006; 15(4); p. 237-44
J; Fernandez-Perez C; Bonet A; Gonzalez-Esteban J
Coca A; Aranda P; Bertomeu V; Bonet A; Esmatjes Revista Clinica espanola; 2006 Nov;
E; Guillen F; Hernandez-Moreno J; Llisterri JL;
206(10); p. 510-4
Marin-Iranzo R; Megia C; Rodriguez-Manas L;
Suarez C;
Llor C, Cots JM , Herreras A
Arch Bronconeumol. 2006; 42:388-9
Llor C, Naberan K, Cots JM, Molina J, Ros F,
Miravitlles M
Arch Bronconeumol 2006;42:175-82
J. Bayó, FX Cos, C. Roca, A. Dalfó, MM MartínBaranera, A. Botey
Blood Presure Monitoring 2006; 11:4752
Poch E, Felip A, Davins J, Coca A
Revista Clínica Española 2006; 206:
541-8
Pepine CJ, Kowey PR, Kupfer S, Kollock RE, Benetos Journal of the American College of
A, Mancia G, Coca A, Cooper-DeHoff RM, Handberg E, Cardiology 2006; 7: 547-51
Gaxiola E, Sleight P, Conti CR, Hewkin AC, Tavazzi L,
for the INVEST Investigators
50
Reducción de la prescripción de
antibióticos en la sinusitis mediante
la realización de una auditoria
Rendiment diagnòstic de
l’automesura se la pressió arterial
domiciliària en la Hipertensió
Clínica Aïllada
Risk factors for increased cost of
exacerbations of chronic bronchitis
and chronic obstructive pulmonary
disease]
Tratamiento y control del riesgo
cardiovascular en atención primaria
en España. Estudio PREVENCAT.
Variabilidad de la prescripción
antibiótica en las infecciones
respiratorias en dos países de
Europa
Revisió
Concerning World Heart Day
Llor C, CotsJM, Molist N, Boada A
Aten Primaria 2006; 38:304-5
J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C.
Medrano
Butlletí de la Societat Catalana de
Medicina Familiar i Comunitària 2006;
24:14-20
Llor C; Naberan K; Cots JM; Molina J; Ros F;
Miravitlles M
Archivos de bronconeumologia; 2006
Apr; 42(4); p. 175-82
Efermedades importadas en
inmigrantes: mito y realidad
Enfoque conjunto de los factores de
riesgo cardiovascular
Ensayos clínicos de
morbimortalidad con
calcioantagonistas en hipertensión.
Estrategias para un control eficaz de
la hipertensión arterial en España.
Documento de Consenso
Estudio ASCOT: prevención de
eventos vasculares con diferentes
combinaciones de fármacos
antihipertensivos: la reducción de la
presión arterial es lo que importa
(en parte)
Importancia del control de la
presión arterial en al reducción de
la morbimortalidad cardiovascular
Inhibidores de la renina
Leptina, obesidad e hipertensión
arterial
Carta
Qualitative indicators in antibiotic
prescription: Are they the most
appropriate ones?
C. Roca, X. Balanzó
Llibre
Avances en hipertensión. Presión
arterial sistólica, presión de pulso y
riesgo cardiovascular
Coca A; Dalfo A; Esmatjes E; Llisterri JL; Ordonez Medicina clinica; 2006 Feb 18; 126(6);
J; Gomis R; Gonzalez-Juanatey JR; Martin-Zurro A p. 201-5
Llor C, Cots JM, Boada A, Bjerrum L, Gahrn-Hansen Enferm Infecc Microbiol Clin 2005;
B, Munck A, et al
23:598-604
Morales A, Coca A
Revista Española de Cardiología 2006;
59:184
An Sist Sanit Nav 2006; 29 (supl
1):139-144
Med Clin (Barc) 2006; 127:774-5
De la Figuera M, Llisterri JL
De la Figuera M
Hipertensión 2006; 23 (extraord. 2);
20-7
Coca A, Aranda P, Bertomeu V; Bonet A, Esmatjes E, SEMERGEN 2006; 32: 30-3
Guillén F, Hernández-Moreno J, Llisterri JL, MarínIranzo R, Megía C, Rodríguez-Mañas L, Suarez C
De la Figuera M
Atención Primaria Basada en la
Evidencia 2006; 1: 184
Coll de Tuero G, De la Figuera M
Drugs Expert 2006. Adis. Madrid
De la Figuera M, Vinyoles E
Vidal J, Coca A
Hipertensión 2006; 23: 216-21
Medicina Clinica (Barc) 2006; 126:
695-696
Llor C; Cots JM; Molist N; Boada A; Bayona C;
Bjerrum L
Atencion primaria / Sociedad
Espanola de Medicina de Familia y
Comunitaria; 2006 Sep 30; 38(5); 3078; author reply 308-9
Coca A y Sierra C
Editorial Juste. Barcelona, 2006.
(Depósito Legal: B-1487-2006)
51
Enfermedad cardiovascular en el
Gil A, Coca A (Ed.)
paciente con hipertensión arterial. El
estudio LIFE. Contribución a la
práctica clínica en hipertensión
arterial
Eventos Cerebrovasculares e
Coca A
Hipertensión Arterial. ¿Qué hemos
aprendido del estudio MOSES?
Jarpyo Editores. Madrid, 2006.
(Depósito Legal: M-42443-2006)
Hipertensión arterial en Atención De la Figuera M, Diogène E, Brotons C (eds)
Primaria. Evidencia y
práctica
clínica.
Manual de monitorización
Coca A, Mion D, Pickering T, Ramos F
ambulatoria de la presión arterial y
técnicas afines
Capítol llibre
Causas de mal cumplimiento del
De la Figuera M
tratamiento
Clasificación y fisiopatología del
ictus, consecuencias y secuelas
Armario P, de la Figuera M
Epidemiologia y factores de riesgo Armario P, de la Figuera M
para el ictus.
La hipertensión arterial en el
síndrome metabólico
Coca A, Sierra C
Patologia infecciosa del tracte
respiratori baix
Bonet Monne S., Casals Font A., Cots Yago JM.,
Falco Ferrer V.,Gonzalez Saavedra MI., Hospital
Guardiola I., Luque Alonso A.,Pahissa Berga A.,
Pericas Bosch J., Serrano de Marco MT.,Simonet
Aineto PJ., Van Esso Arbolave D
Sierra C, Coca A
Presión arterial. Tratamiento
antihipertensivo y riesgo
cardiovascular. Enfermedad
cardiovascular en el paciente con
hipertensión arterial.
Prevención del ictus con el
tratamiento antihipertensivo.
Coca A, de la Figuera M
En Suárez C (coord). Prevención de la
progresión de la enfermedad
cardiovascular.
Importancia
del
cumplimiento terapéutico. Farmacia
Comunicación SL. Madrid 2006; 27-39
En El estudio LIFE. Contribución a la
práctica clínica en hipertensión
arterial. Jarpyo Editores SA. Madrid
2006: 271-77
En El estudio LIFE. Contribución a la
práctica clínica en hipertensión
arterial. Jarpyo Editores SA. Madrid
2006: 261-70
HTA y síndrome metabólico. Acción
Médica grupo. Madrid, 2006. (Depósito
legal: M-52.180-2006)
Guies de practica clinica i material
docent, num. 11. Barcelona: Institut
Catala de la Salut, 2006
El estudio LIFE. Contribución a la
práctica clínica en hipertensión arterial.
Jarpyo Editores. Madrid, 2006.
(Depósito Legal: M-42443-2006)
En El estudio LIFE. Contribución a la
práctica clínica en hipertensión
arterial. Jarpyo Editores SA. Madrid
2006: 323-35
El estudio LIFE. Contribución a la
práctica clínica en hipertensión arterial.
Jarpyo Editores. Madrid, 2006.
(Depósito Legal: M-42443-2006)
El estudio LIFE. Contribución a la
práctica clínica en hipertensión arterial.
Jarpyo Editores. Madrid, 2006.
(Depósito Legal: M-42443-2006)
Depósito legal : B-950-06 JC
Ediciones Médicas, S.L.. Barcelona
(España), Vol 1:1, 2006
Prevención del ictus con el
Coca A, de la Figuera M
tratamiento antihipertensivo.
Enfermedad cardiovascular en el
paciente con hipertensión arterial
Prevención primaria del ictus con el Coca A, Sierra C
tratamiento antihipertensivo.
Conclusiones y recomendaciones
Respiratorio y atención primaria
Editorial Grupo Ars XXI de
Comunicación. Barcelona, 2006. (ISBN
84-9751-190-5 Depósito Legal: M-79402006)
2ª Edición, Barcelona, Euromedice,
2006. ISBN: 84-934482-9-X (obra
completa). 84-96727-00-9 (Volumen I)
Editorial Médica A.W.W.E. S.L. Madrid,
2006. (ISBN 950-762-318-3. Depósito
legal: M-50229-2006)
Torres A, Naberán K
52
Oncologia Clínica
Oncologia Clínica - Publicacions 2006
Titol
Autors
Originals
Activation of nuclear factor-kappa B Montagut C, Tusquets I, Ferrer B, Corominas JM,
is linked to resistance to eoadjuvant Bellosillo B, Campas C, Suarez M, Fabregat X,
chemotherapy in breast cancer
Campo E, Gascón P, Serrano S, Fernández PL,
patients
Rovira A, Albanell J
Biochemotherapy with
González-Cao M, Malvehy, J, Marti, R, Conill C,
temozolomide, cisplatin, vinblastine, Sanchez M, Martin M, Carrera C, Herrero J, Gascon
subcutaneous interleukin-2 and
P, Mellado B, Castel T, Puig S
interferon-[alpha] in patients with
metastatic melanoma
Differential cellular and molecular Codony J, Tapia M, Bosch M, Oliva C, Domingoeffects of bortezomib, a proteasome Domènech J, Mellado B, Rolfe M, Ross J, Gascón P,
inhibitor, in human breast cancer
Rovira A, Albanell J
cells
Evaluation of anaemia in patients Birgegard G, Gascón P, Ludwig H.
with multiple myeloma and
lymphoma: findings of the European
CANCER ANAEMIA SURVEY
Independent Risk Factors For
Barrett-Lee P, Ludwig H, Birgegård G, Bokemeyer
Anemia In Cancer Patients
C, Gascon P, et al
Receiving
Chemotherapy: Results From The
European Cancer Anaemia Survey
(ECAS)
Inhibitors of angiogenesis
Almendro V, Gascón P
Interleukin 6, a Nuclear FactorJ Domingo-Domenech,C Oliva, A Rovira, J
KBTarget, Predicts resistance to
Codony-Servat, M Bosch, X Filella, C Montagut, M
Docetaxel in Hormone-Independent Tapia, C Campa, L Dang, M Rolfe, JS Ross, P
Prostate Cancer and Nuclear
Gascon, J Albanell, and B Mellado
Factor-KB Inhibition by PS-1145
Enhances Docetaxel
AntitumorActivity.
Molecular biology of renal cell
Mellado B, Gascón P
carcinoma
Molecular biology of renal cell
Mellado B; Gascon P
carcinoma.
Phase I trial of gefitinib with
concurrent radiotherapy and fixed 2h gemcitabine infusion, in locally
advanced pancreatic cancer
Time-related improvement of
survival in resectable gastric
cancer: the role of Japanese-style
gastrectomy with D2
lymphadenectomy and adjuvant
chemotherapy
Carta
Cita
Endocr Relat Cancer 13: 607-616,
2006
Melanoma Research 16(1):59-64,
2006
Mol Cancer Ther 5: 665-675, 2006
Eur J Haematol 77(5):378-86, 2006
Oncology 70: 34-48, 2006
Clin Transl Oncol 8: 475-481, 2006
Clin Cancer Res 12: 5578-5586, 2006
Clin Transl Oncol 10: 706-710, 2006
Clinical & translational oncology :
official publication of the Federation of
Spanish Oncology Societies and of the
National Cancer Institute of Mexico;
2006 Oct; 8(10); p. 706-10
Int J Radiat Oncol Biol Phys 66:
*1391-1398, 2006
Maurel J, Martin-Richard M, Conill C, Sanchez M,
Petriz L, Gines A, Miquel R, Gallego R, Cajal R,
Ayuso C, Navarro S, Marmol M, Nadal C, Auge JM,
Fernández-Cruz L, Gascón P
Grau JJ, Palmero R, Marmol M, Domingo-Domènech World J Surg Oncol 4: 53-61, 2006
J, Monzó M, Fuster J, Vidal O, Fondevila C, GarciaValdecasas JC
53
Evaluation of anaemia in patients Birgegard G; Gascon P; Ludwig H
with multiple myeloma and
lymphoma: findings of the European
CANCER ANAEMIA SURVEY
European journal of haematology;
2006 Nov; 77(5); p. 378-86
Oncologia Clínica - Projectes de recerca finançats 2006
Investigador Principal
Gascon P
Referència Ajut
FISS PI041353
Entitat
Nom Projecte
Import
Ministerio de
Efecto del microambiente medular en la integración de las
59.800
Sanidad y Consumo células de cáncer de mama en la metástasis ósea: Papel del gen
PPT-I y del factor TGF-b
Durada
2005-2008
Semiologia General
Semiologia General - Publicacions 2006
Títol
Autors
Original
Association between increased
Cid MC; Hoffman MP; Hernandez-Rodriguez J;
CCL2 (MCP-1) expression in
Segarra M; Elkin M; Sanchez M; Vilardell C; Garcialesions and persistence of disease Martinez A; Pla-Campo M; Grau JM; Kleinman HK
activity in giant-cell arteritis
Atypical autoantibodies in patients Ramos-Casals M; Nardi N; Brito-Zeron P; Aguilo S;
with primary Sjogren syndrome:
Gil V; Delgado G; Bove A; Font J
clinical characteristics and follow-up
of 82 cases
Characterization and differentiation Ramos-Casals M; Sanchez-Tapias JM; Pares A;
of autoimmune versus viral liver
Forns X; Brito-Zeron P; Nardi N; Vazquez P; Velez
involvement in patients with
D; Arias I; Bove A; Plaza J; Rodes J; Font J
Sjogren's syndrome
Diagnostic performance of urinary Zamora-Ros R; Urpi-Sarda M; Lamuela-Raventos
resveratrol metabolites as a
RM; Estruch R; Vazquez-Agell M; Serrano-Martinez
biomarker of moderate wine
M; Jaeger W; Andres-Lacueva C
consumption.
Effects of a Mediterranean-style diet Estruch R; Martinez-Gonzalez MA; Corella D; Salason cardiovascular risk factors: a
Salvado J; Ruiz-Gutierrez V; Covas MI; Fiol M;
randomized trial.
Gomez-Gracia E; Lopez-Sabater MC; Vinyoles E;
Aros F; Conde M; Lahoz C; Lapetra J; Saez G; Ros
E
Evidence of apoptosis in alcoholic Fernandez-Sola J; Fatjo F; Sacanella E; Estruch R;
cardiomyopathy.
Bosch X; Urbano-Marquez A; Nicolas JM
Increased levels of atherosclerosis Larrousse M; Bragulat E; Segarra M; Sierra C; Coca
markers in salt-sensitive
A; de La Sierra A;
hypertension.
Infections in systemic lupus
erythematosus: a prospective and
controlled study of 110 patients
Longitudinal study on mitochondrial
effects of didanosine-tenofovir
combination
Main training in medical specialties:
a challenge of the present for a
better health system
Bosch X; Guilabert A; Pallares L; Cerveral R;
Ramos-Casals M; Bove A; Ingelmo M; Font J
Lopez S; Negredo E; Garrabou G; Puig J; Ruiz L;
Sanjurjo E; Ramos X; Infante AB; Casademont J;
Cardellach F; Clotet B; Miro O
Teres J; Capdevila JA; Nonell F; Cardellach F;
Bundo M; Torres M
54
Cita
Rheumatology (Oxford, England);
2006 Nov; 45(11); p. 1356
Seminars in arthritis and rheumatism;
2006 Apr; 35(5); p. 312-21
The Journal of rheumatology; 2006
Aug; 33(8); p. 1593-9
Clinical chemistry; 2006 Jul; 52(7); p.
1373
Annals of internal medicine; 2006 Jul
4; 145(1); p. 1
Human pathology; 2006 Aug; 37(8); p.
1100-10
American journal of hypertension :
journal of the American Society of
Hypertension; 2006 Jan; 19(1); p. 8793
Lupus; 2006; 15(9); p. 584-9
AIDS research and human
retroviruses; 2006 Jan; 22(1); p. 33-9
Medicina clinica; 2006 Jun 24; 127(4);
p. 139-44
Predictors of adverse outcome
among patients with hypertension
and coronary artery disease
Relation of left ventricular
hypertrophy to regional cerebral
blood flow: single photon emission
computed tomography
abnormalities in essential
hypertension
Scientific evidence of interventions
using the Mediterranean diet: a
systematic review.
Short communication metabolic and
mitochondrial effects of switching
antiretroviral-experienced patients
to enfuvirtide, tenofovir and
saquinavir/ritonavir.
Total polyphenol intake estimated
by a modified Folin-Ciocalteu assay
of urine
Vasculitis in systemic lupus
erythematosus: prevalence and
clinical characteristics in 670
patients
Revisió
¿Cuál es la presión idónea en el
hipertenso de alto riesgo?
White matter lesions and cognitive
impairment as silent cerebral
disease in hypertension
Cas Clínic
Sustained spontaneous clinical
remission in giant cell arteritis:
report of two cases with long-term
followup
Editorial
Towards the best physician for the
community
Carta
Noninvasive diagnosis of
mitochondrial dysfunction in
HAART-related hyperlactatemia
Stimulatory autoantibodies to the
PDGF receptor in scleroderma
Pepine CJ; Kowey PR; Kupfer S; Kolloch RE;
Benetos A; Mancia G; Coca A; Cooper-DeHoff RM;
Handberg E; Gaxiola E; Sleight P; Conti CR; Hewkin
AC; Tavazzi L;
Sierra C, de la Sierra A, Lomeña F, Paré JC,
Larrousse M, Coca A
Journal of the American College of
Cardiology; 2006 Feb 7; 47(3); p. 54751
Serra-Majem L; Roman B; Estruch R
Nutrition reviews; 2006 Feb; 64(2 Pt
2); p. S27-47
Miro O; Garrabou G; Lopez S; Deig E; Vidal I;
Infante AB; Cardellach F; Casademont J; Pedrol E
Antiviral therapy; 2006; 11(5); p. 62530
Roura E; Andres-Lacueva C; Estruch R; LamuelaRaventos RM
Clinical chemistry; 2006 Apr; 52(4); p.
749
The Journal of Clinical Hypertension
2006; 8(10):700-705
Ramos-Casals M; Nardi N; Lagrutta M; Brito-Zeron Medicine; 2006 Mar; 85(2); p. 95-104
P; Bove A; Delgado G; Cervera R; Ingelmo M; Font J
Coca A, Sierra C
Jano 2006; 1597: 47-50
Sierra C, Coca A
Scientific World Journal 2006; 6: 494501
Hernandez-Rodriguez J; Garcia-Martinez A; Espigol- Arthritis and rheumatism; 2006 Feb
Frigole G; Grau JM; Collado A; Cid MC
15; 55(1); p. 160-2
Cardellach F; Vilardell M
Medicina clinica; 2006 Jun 24; 127(4);
p. 136-8
Garrabou G; Sanjurjo E; Miro O; Martinez E; Infante Clinical infectious diseases : an official
AB; Lopez S; Cardellach F; Gatell JM; Casademont publication of the Infectious Diseases
J
Society of America; 2006 Feb 15;
42(4); p. 584-5
Lozano E; Segarra M; Cid MC
The New England journal of medicine;
2006 Sep 21; 355(12); p. 1278
Semiologia General - Projectes de recerca finançats -2006
Investigador
Principal
Cardellach F
Referència
Ajut
PI041239
Entitat
Nom Projecte
Fondo de
Intoxicación por monóxido de carbono: tratamiento con oxigeno
Investigación Sanitaria normobarico o hiperbarico y su correlación con la actividad del
complejo IV mitocondrial y el grado de peroxidación lipidica de
linfocitos de sangre periferica
55
Import
94.990
Durada
2005-2007
Casademont J
Red-G003/11 MSCO – Ministerio de Estudio clínico-epidemiológico y molecular de las enfermedades de 20.147,65
022681 Ordre: Sanidad y Consumo la cadena respiratoria mitocondrial en España
015
2004-2006
Cid MC
SAF200506250
Ministerio de
Educación y Ciencia
Factores relacionados con el mantenimiento de la inflamación y la
oclusión vascular. Implicaciones en la evolución clínica de los
pacientes con arteritis de células gigantes
140.420
2005-2008
Cid MC
SAF200506250
Ministerio de
Educación y Ciencia
Factores relacionados con el mantenimiento de la inflamación y la
oclusión vascular. Implicaciones en la evolución clínica de los
pacientese con arteritis de células gigantes
140.420
2005-2008
Estruch R
PI051519
FIS
Efectos de la dieta mediterrànea en la prevención de la enfermedad 70.329
cardiovascular
2006
Estruch R
AGL200614228-C0301/ALI
MEC
Balance beneficio/riesgo del contenido de polifenoles y alcohol del
vino
32.000
2006-2008
Estruch R
AGL200408378-C02-02
MEC
Biodisponibilidad de los fenoles del cacao: Bases científicas de la
interacción de los fenoles y los marcadores inflamatorios de la
arteriosclerosis
115.000
2005-2007
Estruch R
PI041837
FIS
Mecanismos básicos de los efectos de la dieta mediterránea sobre
la enfermedad cardiovascular
84.525
2004-2006
Fundación Privada
MAPFRE-Medicina
Evaluación de parámetros de calidad de vida y recuperación
9.000
funcional de pacientes con fatiga crónica en los diveros estadíos de
la enfermedad.
Febrero 2005Marzo 2006
Grup de Recerca Múscular
35.600
2005-2007
Fernandez Sola J
Grau JM
2005SGR00300 Agencia de Gestió
d´Ajuts Universitaris i
de Recerca
Grau JM
PI04464
Fondo de
Angiogénesis y citocinas como factores pronósticos en la
Investigación Sanitario dermatomiositis. Caracterización del síndrome antisintetasa
31.050
2005-2007
Grau JM
FIS PI040464
FIS
Angiogénesis y citocinas como factores pronósticos en la
dermatomiositis. Caracterización del síndrome antisintetasa
31.050
2004-2006
Nicolas JM
PI050164
FIS
Marcadores biológicos del fracaso multiorgánico en el shock séptico 60.000
2005-2008
Hospitals Col·laboradors
Publicacions Hospitals Col·laboradors
Títol
Autors
Original
Automedida de la presión arterial J. Bayó, C. Roca, A. Dalfó, MM Martin-Baranera, KX
domiciliaria. Influencia del sistema Naberan, A. Botey
de cáculo de la media en el
diagnóstico de la Hipertensión de
bata blanca
Cardiovascular risk factors in
Arboix A; Miguel M; Ciscar E; Garcia-Eroles L;
patients aged 85 or older with
Massons J; Balcells M
ischemic stroke
Clinical implications of headache in Arboix A; Grau-Olivares M; Garcia-Eroles L;
lacunar stroke: relevance of site of Massons J; Comes E; Targa C
infarct
Clinical study of 39 patients with
Arboix A; Lopez-Grau M; Casasnovas C; Garciaatypical lacunar syndrome
Eroles L; Massons J; Balcells M
Clustering of cardiovascular risk
factors and prevalence of metabolic
syndrome in subjects with resistant
hypertension
Determinants of early outcome in
spontaneous lobar cerebral
hemorrhage
Hernandez del Rey R; Armario P; Martin-Baranera
M; Castellanos P
Arboix, Manzano C, García-Eroles L, Massons J,
Oliveres M, Parra O, Targa C
56
Cita
Aten Primaria 2006;38:212-8
Clinical neurology and neurosurgery;
2006 Oct; 108(7); p. 638-43
Headache; 2006 Jul-Aug; 46(7); p.
1172-80
Journal of neurology, neurosurgery,
and psychiatry; 2006 Mar; 77(3); p.
381-4
Medicina clinica; 2006 Jul 15; 127(7);
p. 241-5
Acta Neurol Scand 2006; 114:187-92
Differences in the etiology of
community-acquired penumonia
according to site of care: A
population-based study
Home blood presure self-monitoing:
diagnostic performance in whitecoat hypertension
Impact of female gender on
prognosis in type 2 diabetic patients
with ischemic stroke
NARP-MILS syndrome caused by
8993 T > G mitochondrial DNA
mutation: a clinical, genetic and
neuropathological study
Prevalence of hypertension in
elderly long-term care residents in
Spain. The Geriatric HTA study
Prognostic value of headache in
cardioembolic stroke
Quilotorax y ascitis quilosa.
Manifestación inicial de un
Síndrome Nefrótico
Rendiment diagnòstic de
l’automesura se la pressió arterial
domiciliària en la Hipertensió
Clínica Aïllada
Risk factors for hospital readmission
in patients with chronic obstructive
pulmonary disease
Revisió
Efermedades importadas en
inmigrantes: mito y realidad
Hepatitis B en situaciones
especiales
Almirall J. Et al. GEMPAC Study Group (... O.
Parra...)
Respiratory Medicine 2007; 101:216875
J. Bayó, FX Cos, C. Roca, A. Dalfó, MM MartínBaranera, A. Botey
Blood Presure Monitoring 2006; 11:4752
Arboix A; Milian M; Oliveres M; Garcia-Eroles L;
Massons J
European neurology; 2006; 56(1); p. 6
Nocturnal hypoxia is associated
with silent cerebrovascular disease:
An original approach
Cas Clínic
Tuberculosis, ancylostomiasis and
eosinophilic pleural effusion
Lllibre
Métodos diagnósticos en las
enfermedades vasculares
cerebrales (2 edición)
Capítol llibre
Colitis colágena y linfocítica
Parra O
Ecocardiografía
Alió J, Ruiz-Majoral A, Arboix A
Rojo A; Campos Y; Sanchez JM; Bonaventura I;
Acta neuropathologica; 2006 Jun;
Aguilar M; Garcia A; Gonzalez L; Rey MJ; Arenas J; 111(6); p. 610-6
Olive M; Ferrer I
Martin-Baranera M; Sanchez Ferrin P; Armario P
Medicina clinica; 2006 Nov 11;
127(18); p. 681-7
Arboix A
Medicina clinica; 2006 Jun 3; 127(1);
p. 5-7
Med Clin 2006; 127:718
Bonnin. M, Pelegrí A, Parra O
J. Bayó, C. Roca, A. Dalfó, MM Martín-Baranera, C.
Medrano
Butlletí de la Societat Catalana de
Medicina Familiar i Comunitària 2006;
24:14-20
Almagro P; Barreiro B; Ochoa de Echaguen A;
Quintana S; Rodriguez Carballeira M; Heredia JL;
Garau J
Respiration; international review of
thoracic diseases; 2006; 73(3); p. 311
C. Roca, X. Balanzó
An Sist Sanit Nav 2006; 29 (supl
1):139-44
Gastroenterologia y Hepatologia 2006;
29(supl 2):16-81
Torres M
Am J Hypertens. 2006 Aug;19(8):8767
Rodriguez E; Delgado Y; Buges J; Bastida T; Torres Anales de medicina interna (Madrid,
M
Spain : 1984); 2006 Jan; 23(1); p. 46-7
Arboix A
Ed. Ergon ed, Madrid. 2006. ISBN: 848473-451-X M-10959-2006
Fernández-Bañares F, Viver JM
En: Tratamiento de las enfermedades
gastroenterológicas. Ponce J ed.
Ediciones Doyma S.L. Barcelona,
2006; Capítulo 32, p. 295-300
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
57
Electrocardiograma
Arboix A, Martorell E, Alió J
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Examen físico general
Arboix A, Martí-Vilalta JL
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Historia Clínica
Martí-Vilalta Jl, Martí-Fàbregas J, Arboix A
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Ictus: tipos etiológicos y criterios
Arboix A, Díaz J, Pérez-Sempere A, Alvarez-Sabín J En: Guía para el diagnóstico y
diagnóstico
tratamiento del ictus. Guías oficiales
de la Sociedad Española de
Neurología. Ed. Prous Science SA,
Barcelona. 2006.ISBN: 84-8124-225-X
Métodos diagnósticos en el infarto Arboix A, Dávalos A
En: Métodos diagnósticos en las
cerebra
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Métodos diagnósticos en el infarto Massons J, Arboix A
En: Métodos diagnósticos en las
migrañoso
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Polisomnografía
Parra O
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición). Arboix A (ed). Ed.Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Presentación
Arboix A
En: Métodos diagnósticos en las
enfermedades vasculares cerebrales
(2 edición) Arboix A (ed). Ed. Ergon
ed, Madrid. 2006. ISBN: 84-8473-451X
Profilaxis primaria y secundaria de Torres M
En: Planas Vilà R, Solà Lamoglia R,
la hepatitis B
eds. Hepatitis B. Manual para
Atención Primaria. Barcelona: Mayo
Ediciones, 2006. ISBN84-96537-30-7
Trastornos de la respiración durante Parra O, Arboix A
En: Santamaria J ed. Continua
el sueño y accidente vascular
Neurológica. Trastornos del sueño.
cerebral
Barcelona. Grupo ARS XXI de
Comunicación 2006. ISBN
849751237.
Hospitals col·laboradors - Projectes de recerca finançats 2006
Investigador
Principal
Torres M
Referència
Ajut
PI03/1131
Entitat
Instituto de
Investigación Carlos
III
Nom Projecte
Accidentes biológicos parenterales en el personal
sanitario. Análisis de los factores prevenibles mediante
precauciones estándar
58
Import
3.450
Durada
2004-2006
Economia
59
60
Despeses Funcionament Ordinari 2006
Beca col·laboració
Biblioteca/Documentació
Correu/Missatgeria
Equipament Inventariable Secretaria
Fotografia
Funcionament
Habilitats Clíniques
Material Docent Inventariable
Material oficina/fotocòpies
Microscopia Electrònica
Reparacions
Software
Telèfon
Xarxa
4.851,00
495,45
554,83
1.859,45
85,72
171,21
25.340,00
8.332,43
5.740,99
157,85
121,86
433,49
449,29
400,80
Total assignació 2006
48.994,37
Despeses Funcionament Ordinari 2006
Habilitats Clíniques
Material Docent Inventariable
Material oficina/fotocòpies
Beca col·laboració
Equipament Inventariable
Secretaria
Correu/Missatgeria
Biblioteca/Documentació
Telèfon
Software
Xarxa
+
61